<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS158981</article-id><article-id pub-id-type="doi">10.1101/2022.12.22.521159</article-id><article-id pub-id-type="archive">PPR588446</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">2</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>RNF43 mutations facilitate colorectal cancer metastasis via formation of a tumour-intrinsic niche</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bugter</surname><given-names>Jeroen M.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>El Bouazzaoui</surname><given-names>Layla</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Küçükköse</surname><given-names>Emre</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Yourae</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Sprangers</surname><given-names>Joep</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jordens</surname><given-names>Ingrid</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fenderico</surname><given-names>Nicola</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gonzalez</surname><given-names>Diego Montiel</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>van Boxtel</surname><given-names>Ruben</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Suijkerbuijk</surname><given-names>Saskia J.E.</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Tejpar</surname><given-names>Sabine</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Snippert</surname><given-names>Hugo J.G.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kranenburg</surname><given-names>Onno</given-names></name><xref ref-type="aff" rid="A5">5</xref><xref ref-type="corresp" rid="CR1">✉</xref></contrib><contrib contrib-type="author"><name><surname>Maurice</surname><given-names>Madelon M.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">✉</xref></contrib></contrib-group><aff id="A1"><label>1</label>Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, the Netherlands</aff><aff id="A2"><label>2</label>Department of Surgical Oncology, Lab Translational Oncology, UMC Utrecht, the Netherlands</aff><aff id="A3"><label>3</label>Department of Oncology, Katholieke Universiteit Leuven, Belgium</aff><aff id="A4"><label>4</label>Princes Maxima Centre for Pediatric Oncology, Utrecht, the Netherlands</aff><aff id="A5"><label>5</label>Division of Developmental Biology, Institute of Biodynamics and Biocomplexity, Department of Biology, Faculty of Science, Utrecht University, The Netherlands</aff><author-notes><corresp id="CR1"><label>✉</label>corresponding authors; <email>o.kranenburg@umcutrecht.nl</email> &amp; <email>m.m.maurice@umcutrecht.nl</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>24</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>23</day><month>12</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><title>Summary</title><p id="P1">In colorectal cancer (CRC), <italic>RNF43</italic> mutations are linked to BRAF V600E-initiated serrated adenomas that advance into mucinous adenocarcinomas with poor prognosis upon metastasis. How <italic>RNF43</italic> mutations facilitate a metastasis-prone growth state remains unknown. Here, we addressed this issue by repairing mutant <italic>RNF43</italic> in patient-derived BRAF-mutant CRC organoids using gene editing. Upon <italic>RNF43</italic> correction, CRC organoids exhibit strongly decreased mucus production and, moreover, display loss of niche factor independence and metastatic capacity upon orthotopic transplantation in mice. Mechanistically, we show that mutant RNF43 promotes cancer cell lineage specification towards a non-dividing niche population that secretes essential growth factors, providing a state of self-sufficiency to the cancer epithelium. We show that phenotypic diversification into tumour-intrinsic niche cells (TINCs) and proliferative cancer stem cells depends on tuneable WNT levels enabled by mutations in <italic>RNF43</italic>, but not <italic>APC</italic>. In patient samples, enhanced TINC profiles correlate with <italic>RNF43</italic>-mutant CRC, mucinous histology and metastatic disease, thus representing a general cellular mechanism by which tumours acquire a self-sufficient, pro-metastatic growth state.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Self-renewal of human colon adult stem cells is controlled by specialized epithelial and mesenchymal niche cells that secrete essential factors to promote growth and prevent differentiation<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Identification of the essential stem-cell niche factors such as WNT, EGF and BMP-antagonists has led to the establishment of <italic>in vitro</italic> culture conditions for intestinal organoids<sup><xref ref-type="bibr" rid="R2">2</xref></sup>. Different from healthy adult colon stem cells, patient-derived colorectal cancer (CRC) cells commonly display loss of niche factor-dependency during <italic>in vitro</italic> outgrowth into organoids, which correlates with their metastatic capacity <italic>in vivo</italic><sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref></sup>. In the classical view, the adenoma-carcinoma transition is driven by an accumulation of mutations (e.g. <italic>APC/KRAS/SMAD)</italic> that endow tumour cells with stem cell-like properties while omitting the need for a specialized niche<sup><xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R5">5</xref></sup>.</p><p id="P3">CRC is however a heterogeneous disease and can develop via two mutually exclusive genetic pathways with distinct molecular and clinical manifestations<sup><xref ref-type="bibr" rid="R6">6</xref>–<xref ref-type="bibr" rid="R9">9</xref></sup>. 15-30% of sporadic CRCs develop via a distinct route, commonly referred to as the serrated neoplasia pathway that is typically initiated by an oncogenic BRAF mutation and is mutually exclusive with WNT activating APC mutation. In contrast to <italic>APC</italic>-induced adenomas, serrated lesions do not present with an expansion of the classical stem-cell program and retain properties related to differentiated colon epithelium<sup><xref ref-type="bibr" rid="R9">9</xref></sup>. Upon acquiring a mutation in the negative WNT pathway regulator RNF43, serrated lesions can advance into mucinous adenocarcinomas with poor prognosis upon metastasis<sup><xref ref-type="bibr" rid="R9">9</xref>–<xref ref-type="bibr" rid="R12">12</xref></sup> Despite their frequent occurrence, the mechanism by which <italic>RNF43</italic> mutations contribute to tumour progression and metastatic spread has thus far remained unclear.</p><p id="P4">Importantly, <italic>RNF43/BRAF-mutant</italic> CRC remains sensitive to inhibition of upstream WNT and EGF signalling<sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup>. Notwithstanding their WNT dependence, <italic>RNF43/BRAF-mutant</italic> tumours are characterized by relatively low levels of WNT target gene expression and high mucus production<sup><xref ref-type="bibr" rid="R15">15</xref></sup>. How these epithelial cancer subsets acquire the capacity to generate their own growth factors to drive a self-sufficient growth state remains unknown.</p><p id="P5">Here, we investigated the functional driver role of <italic>RNF43</italic> mutations in late stage, metastasis-prone BRAF V600E-mutant mucinous adenocarcinoma. We employed CRISPR-mediated gene editing to repair RNF43 mutations in patient-derived CRC organoids, and examined consequences for cancer epithelial organization, growth factor dependencies and <italic>in vivo</italic> tumour growth and metastatic capacity. Our findings uncover a driver mechanism that involves the formation of specialized niche-factor producing cells, which permits an autonomous, pro-metastatic growth state that relies on self-organized interactions between dividing and non-dividing cancer cell populations.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>RNF43 mutation repair in patient-derived organoids eliminates metastatic capacity and niche-independent outgrowth</title><p id="P6">To investigate whether common differences in transcriptional profiles between <italic>RNF43</italic>-mutant and <italic>APC</italic>-mutant CRC are maintained in organoid culture conditions, we compared RNAseq data of a panel of representative human patient-derived CRC organoids (<xref ref-type="fig" rid="F1">Figure 1A</xref>). In agreement with previous reports<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R15">15</xref></sup>, <italic>RNF43</italic>-mutant CRC organoids displayed relatively low levels of WNT target gene expression and an increased expression of mucin-related genes (<xref ref-type="fig" rid="F1">Figure 1A</xref>). To address the functional driver role of mutated <italic>RNF43</italic>, we selected the <italic>RNF43/BRAF-mutant</italic> human CRC organoid line HUB040, derived from a primary human mucinous colorectal adenocarcinoma that presented with prominent metastasis in the patient<sup><xref ref-type="bibr" rid="R16">16</xref></sup>. Different from healthy colon organoids<sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R13">13</xref></sup>, HUB040 can be propagated without supplementation of WNT, RSPO and EGF, indicating that this tumour acquired a state of growth factor self-sufficiency (<xref ref-type="fig" rid="F1">Figure 1B</xref>). As expected, based on its <italic>RNF43</italic>-mutant status, HUB040 was sensitive to treatment with Porcupine inhibitors, confirming its dependency on self-produced WNTs (<xref ref-type="fig" rid="F1">Figure 1C</xref>) <sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R13">13</xref></sup>. We employed gene editing to correct the mutated <italic>RNF43</italic> locus to wildtype and obtained two <italic>RNF43-corrected</italic> clones (RC1, RC2) and one non-corrected control clone (NC1) (<xref ref-type="fig" rid="F2">Figures 2A</xref> and <xref ref-type="fig" rid="F2">2B</xref>). Whole genome sequencing of all clones confirmed preservation of pre-existing HUB040 driver mutations, other than <italic>RNF43</italic> (<xref ref-type="supplementary-material" rid="SD3">Figure S1A</xref>). Karyotypes of HUB040, NC1 and RC2 were similar, while RC1 was somewhat divergent, mainly due to whole genome duplication (<xref ref-type="supplementary-material" rid="SD3">Figures S1B-G</xref>). To investigate metastatic capacity, we performed orthotopic transplantation of organoids into the caecal wall of immune-deficient mice<sup><xref ref-type="bibr" rid="R17">17</xref></sup>. After 120 days, HUB040 and NC1 had formed primary tumours that spontaneously metastasized to the lungs and the liver (<xref ref-type="fig" rid="F2">Figures 2C</xref>, <xref ref-type="fig" rid="F2">2D</xref> and <xref ref-type="supplementary-material" rid="SD3">S2A</xref>). Strikingly, for transplanted <italic>RNF43</italic>-corrected organoids no metastatic lesions were detected (<xref ref-type="fig" rid="F2">Figures 2C</xref> and <xref ref-type="fig" rid="F2">2D</xref>), even though their primary tumour load equalled that of <italic>RNF43</italic>-mutant counterparts (<xref ref-type="supplementary-material" rid="SD3">Figure S2A</xref>). Thus, by restoring a single mutation we eliminated the metastatic capacity of this aggressive cancer model. These data suggest a key role for mutated <italic>RNF43</italic> in promoting metastasis.</p><p id="P7">Next, we assessed organoid niche-independency by performing single cell reconstitution assays in growth factor-depleted conditions. Like HUB040, <italic>RNF43</italic>-mutant NC1 organoids retained their capacity to expand in medium lacking extrinsic growth factors (<xref ref-type="fig" rid="F2">Figures 2E</xref>, <xref ref-type="supplementary-material" rid="SD3">S2B</xref> and <xref ref-type="supplementary-material" rid="SD3">S2C</xref>). By contrast, <italic>RNF43</italic>-repaired lines RC1 and RC2 acquired a strong dependence on supplementation with WNT, RSPO and EGF (<xref ref-type="fig" rid="F2">Figures 2E</xref>, <xref ref-type="supplementary-material" rid="SD3">S2B</xref> and <xref ref-type="supplementary-material" rid="SD2">S2C</xref>). These results were unexpected, as introduction of <italic>RNF43</italic> mutations in healthy human colon-derived or mouse intestinal organoids are known to enhance WNT sensitivity<sup><xref ref-type="bibr" rid="R10">10</xref></sup>, but are not known to alter EGF dependency. Our data thus imply a role for <italic>RNF43</italic> mutations in promoting cancer cell survival and growth in the absence of growth factor supplementation.</p></sec><sec id="S4"><title>Mutant <italic>RNF43</italic> drives mucinous differentiation and niche factor production</title><p id="P8">We next aimed to investigate how <italic>RNF43</italic> mutations affect tumour phenotype. Transcriptome comparison of HUB40, NC1 and both RC organoid lines yielded a mutant <italic>RNF43</italic>-driven gene expression signature that comprised numerous genes encoding growth factors and mucins (<xref ref-type="fig" rid="F3">Figures 3A</xref>, <xref ref-type="fig" rid="F3">3B</xref>, <xref ref-type="supplementary-material" rid="SD3">S2D and S2E</xref>). In line with these findings, gene sets representing Goblet and Deep Crypt Secretory (DCS) cells of healthy colon were significantly depleted from RC1 and RC2 in comparison to control lines (<xref ref-type="fig" rid="F3">Figure 3C</xref>)<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup>. Furthermore, <italic>RNF43</italic>-mutant tumours displayed extensive mucus secretion <italic>in vitro</italic> and <italic>in vivo</italic>, while this property was strongly diminished upon <italic>RNF43</italic> correction (<xref ref-type="fig" rid="F3">Figures 3D-F</xref>), strengthening the observation that <italic>RNF43</italic> mutations facilitate secretory cell differentiation.</p><p id="P9">Notably, the <italic>RNF43</italic>-mutant signature comprised several reported niche factors including <italic>IGF2, VEGFA, DLL1/4</italic> and <italic>WNT8B</italic> (<xref ref-type="fig" rid="F3">Figures 3A</xref>, <xref ref-type="fig" rid="F3">3B</xref> and <xref ref-type="supplementary-material" rid="SD3">S2E</xref>). Blocking upstream IGF and WNT signalling diminished reconstitution capacity of HUB40 CRC organoids, which was rescued by supplementation with exogenous EGF or WNT ligands, respectively (<xref ref-type="fig" rid="F3">Figures 3G and 3H</xref>), reminiscent of the growth state of <italic>RNF43-corrected</italic> organoids (<xref ref-type="fig" rid="F2">Figures 2E</xref> and <xref ref-type="supplementary-material" rid="SD3">S2B</xref>). Based on these data, we hypothesized that <italic>RNF43</italic> mutations accommodate the production of self-produced niche-factors that are essential for tumour survival and growth. To test this, we generated hybrid co-cultures of <italic>RNF43</italic>-mutant and <italic>RNF43</italic>-corrected organoids and monitored them over time in growth factor-depleted medium using live imaging (<xref ref-type="fig" rid="F3">Figure 3I</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Videos 1</xref>-<xref ref-type="supplementary-material" rid="SD2">2</xref>)<sup><xref ref-type="bibr" rid="R20">20</xref></sup>. While cultures of unmixed <italic>RNF43</italic>-corrected organoids displayed a high ratio of cell death over mitotic events, this ratio was reversed when <italic>RNF43</italic>-corrected cells shared a lumen with <italic>RNF43</italic>-mutant cells (<xref ref-type="fig" rid="F3">Figure 3J</xref>). These results confirm that HUB040 CRC survival relies on paracrine signalling events that are facilitated by mutant RNF43.</p></sec><sec id="S5"><title>Mutant <italic>RNF43</italic> promotes tumour-intrinsic niche cell formation</title><p id="P10">In a previous study, we showed that inactivation of <italic>Rnf43</italic> and its paralogue <italic>Znrf3</italic> in the mouse small intestine induces hyperplasia of stem cells as well as secretory Paneth cells, that function as an intra-epithelial stem cell niche<sup><xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R22">22</xref></sup>. To investigate how <italic>RNF43</italic> mutations may promote the formation of specialized niche factor-producing cells within human CRC, we first performed single cell RNA sequencing analysis of the HUB040 organoid line. Single cell profiles spanned seven clusters with distinct expression patterns discovered by unsupervised clustering (<xref ref-type="fig" rid="F4">Figures 4A</xref> and <xref ref-type="supplementary-material" rid="SD3">S3A</xref>). Noticeably, one population of cells (cluster 1), representing about one-sixth of tumour cells, entirely lacked expression of proliferation and stem cell-related genes<sup><xref ref-type="bibr" rid="R23">23</xref></sup> (<xref ref-type="fig" rid="F4">Figures 4B, 4C</xref> and <xref ref-type="supplementary-material" rid="SD3">S3B</xref>). Instead, this subset displayed prominent hallmarks of differentiated secretory niche cells, as exemplified by the expression of gene sets related to Goblet cells (<xref ref-type="fig" rid="F4">Figure 4D</xref>), Deep Crypt Secretory (DCS) cells (<xref ref-type="fig" rid="F4">Figure 4E</xref>)<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup>, hypoxia and glycolysis (<xref ref-type="supplementary-material" rid="SD3">Figures S3C-E</xref>)<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup>, as well as mTOR activation and the unfolded protein response (<xref ref-type="supplementary-material" rid="SD3">Figure S3E</xref>)<sup><xref ref-type="bibr" rid="R26">26</xref>–<xref ref-type="bibr" rid="R28">28</xref></sup>. We thus identified cluster 1 as a non-proliferating, niche factor-producing secretory cancer cell subset that we call tumour-intrinsic niche cells (TINCs).</p><p id="P11">Subjection of healthy colon organoids to growth factor depletion caused emergence of a TINC and DCS signature-enriched cell population, supporting the observation that TINCs share identity with differentiated, healthy DCS cells (<xref ref-type="supplementary-material" rid="SD3">Figure S4</xref>)<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. Notably, the TINC gene signature was significantly downregulated in both RNF43-corrected clones (<xref ref-type="supplementary-material" rid="SD3">Figure S3F</xref>). scRNAseq analysis of all clones in complete medium revealed that 16% of both HUB040 and NC1 cells displayed high expression of the full TINC signature which was reduced to 1-7% of cells within RNF43-corrected clones (<xref ref-type="fig" rid="F4">Figure 4F</xref>). In agreement, expression of prominent TINC markers was diminished in RNF43-corrected clones (<xref ref-type="fig" rid="F4">Figure 4G</xref>). Based on these findings, we conclude that TINC formation is promoted by mutant RNF43.</p></sec><sec id="S6"><title><italic>RNF43</italic>-mutant organoids self-organize into proliferating stem cells and non-proliferating supporting niche cells</title><p id="P12">To characterise mutant <italic>RNF43-dependent</italic> TINC cells, we focussed on <italic>NDRG1</italic>, that we identified as a prominent marker gene for TINCs in HUB40 organoids, and for DCS cells in healthy colon organoids (<xref ref-type="supplementary-material" rid="SD3">Figures S3G</xref> and <xref ref-type="supplementary-material" rid="SD3">S4I</xref>). Introduction of an IRES-linked mNeon green fluorophore within the <italic>NDRG1</italic> gene revealed that TINCs are heterogeneously distributed within HUB040 (<xref ref-type="fig" rid="F4">Figures 4H, 4I</xref> and <xref ref-type="supplementary-material" rid="SD3">S5A</xref>). Non-dividing NDRG1<sup>high</sup> TINC reporter cells were interspersed with proliferative NDRG1<sup>low</sup> cells as shown by KI67 labelling (<xref ref-type="fig" rid="F4">Figure 4I</xref>) and EdU incorporation (<xref ref-type="fig" rid="F4">Figure 4J</xref>). Despite their differentiated and non-proliferative appearance, TINCs retained regenerative capacity, as isolated NDRG1<sup>high</sup>, NDRG1<sup>medium</sup> and NDRG1<sup>low</sup> single cells gave rise to fully grown organoids in which the heterogeneous distribution of TINCs was restored (<xref ref-type="fig" rid="F4">Figures 4K</xref> and <xref ref-type="supplementary-material" rid="SD3">S5B</xref>). Our data thus reveal that <italic>RNF43/BRAF-mutant</italic> HUB040 CRC organoids display phenotypic heterogeneity and are capable of self-organising into a mixture of non-proliferative TINCs and stem-like cell populations.</p><p id="P13">An in-depth transcriptome characterization of sorted NDRG1<sup>high</sup> cells compared to sorted NDRG1<sup>medium</sup> and NDRG1<sup>low</sup> cells (<xref ref-type="supplementary-material" rid="SD3">Figures S5C-E</xref>) generated an ‘extended TINC signature’ of about 1.000 genes that robustly confirmed previously identified TINC hallmarks (<xref ref-type="supplementary-material" rid="SD3">Figures S5F, S5G</xref> and <xref ref-type="supplementary-material" rid="SD3">S3E</xref>), including mutant <italic>RNF43</italic>-dependent niche factors such as <italic>IGF2, Dll1, IGFBP2</italic> and <italic>VEGFA</italic> (<xref ref-type="fig" rid="F4">Figures 4L</xref> and <xref ref-type="fig" rid="F3">3M</xref>). Intriguingly, TINCs displayed a relatively decreased expression of WNT target genes, including <italic>RNF43</italic> itself (<xref ref-type="fig" rid="F4">Figure 4M</xref>). These results support a model in which <italic>RNF43</italic> mutations allow for tuneable WNT signalling and intra-tumoural lineage diversification, even though all cells are <italic>RNF43</italic>-mutant. Lastly, marker genes related to regeneration (<italic>ANXA1</italic>) and metastatic relapse (<italic>EMP1</italic>) were enriched in TINCs (<xref ref-type="fig" rid="F4">Figure 4M</xref>)<sup><xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref></sup>. We conclude that <italic>RNF43</italic> mutations facilitate tumour cell differentiation into niche factor-producing cells, which explains the acquired niche-independent growth state of these tumours.</p></sec><sec id="S7"><title>TINCs are enriched in <italic>RNF43</italic>-mutant human CRC and metastatic lesions</title><p id="P14">We next explored the broader relevance of TINCs for human CRC. TINC marker gene expression was significantly enriched in <italic>RNF43</italic>-mutant as well as mucinous CRC subtypes of the cancer genomics atlas (TCGA) (<xref ref-type="fig" rid="F5">Figures 5A</xref> and <xref ref-type="fig" rid="F5">5B</xref>). Moreover, TINC gene expression was significantly enhanced in lung and liver metastases compared to primary colorectal tumours (<xref ref-type="fig" rid="F5">Figures 5C</xref> and <xref ref-type="supplementary-material" rid="SD3">S6A</xref>). At the single cell level, CRC tumours were recently classified into two intrinsic epithelial subtypes<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. Among these, TINC signature expression was highest in the iCMS3 group, in which <italic>RNF43</italic> mutations are predominantly found (<xref ref-type="fig" rid="F5">Figure 5D</xref>)<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. Furthermore, within iCMS3 tumours, TINC signature expression was higher in <italic>RNF43-mutant</italic> compared to <italic>RNF43</italic> wildtype cases (<xref ref-type="fig" rid="F5">Figure 5D</xref>). We corroborated these findings by re-analysis of 18.320 single cell transcriptomes derived from CRC tumours of 28 patients, of which four were <italic>RNF43</italic> mutant<sup><xref ref-type="bibr" rid="R6">6</xref></sup> (<xref ref-type="supplementary-material" rid="SD3">Figure S6D</xref>). Supervised clustering with batch correction resolved eight shared CRC cell clusters. In comparison with <italic>RNF43</italic> wildtype CRC, <italic>RNF43</italic>-mutant CRC accumulated a larger fraction of cells within two clusters (cluster 3 and 5) (<xref ref-type="fig" rid="F5">Figures 5E, 5F</xref> and <xref ref-type="supplementary-material" rid="SD3">S6E</xref>) that were enriched for <italic>RNF43</italic>-regulated genes (<xref ref-type="supplementary-material" rid="SD3">Figure S6G</xref>). Additionally, cluster 5 was enriched for goblet cell markers, while TINC markers mapped to cluster 3, exemplified by high <italic>NDRG1</italic> expression (<xref ref-type="fig" rid="F5">Figures 5G</xref> and <xref ref-type="supplementary-material" rid="SD3">S6G</xref>). Thus, <italic>RNF43-mutant</italic> CRC subsets are not only enriched for TINC marker expression but also display an overall increased fraction of TINCs (<xref ref-type="supplementary-material" rid="SD3">Figure S6F</xref>).</p></sec><sec id="S8"><title>Tuneable WNT signalling balances the formation of stem cells and supporting tumour niche cells</title><p id="P15">The fraction of TINCs was lowest in iCMS2 subgroups that is often driven by <italic>APC</italic> mutations and high WNT signalling (<xref ref-type="fig" rid="F5">Figure 5D</xref>)<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. In line, TINC marker gene expression inversely correlated with high WNT signalling and <italic>APC</italic> mutations when analysed in TCGA (<xref ref-type="supplementary-material" rid="SD3">Figures S6B</xref> and <xref ref-type="supplementary-material" rid="SD3">S6C</xref>). To investigate how <italic>APC</italic> mutations affect WNT signalling and TINC formation in context of a non-iCMS2 tumour, we introduced a conventional truncating mutation in the <italic>APC</italic> mutation cluster region of the HUB040 organoid. Surprisingly, and in contrast to healthy colon organoids<sup><xref ref-type="bibr" rid="R31">31</xref></sup>, biallelic targeting of <italic>APC</italic> was rather inefficient in HUB040 (<xref ref-type="supplementary-material" rid="SD3">Figure S7A</xref>), in line with the observed mutual exclusivity of <italic>APC</italic> mutations in <italic>BRAF/RNF43-mutant</italic> human cancers<sup><xref ref-type="bibr" rid="R32">32</xref></sup>. Compared to HUB040<sup>APC+/-</sup> clones that we obtained, HUB040<sup>APC-/-</sup> organoid clones displayed prominent WNT/β-catenin target gene expression, enhanced nuclear β-catenin levels and acquired resistance to treatment with WNT secretion inhibitors (<xref ref-type="fig" rid="F6">Figures 6A, 6B</xref> and <xref ref-type="supplementary-material" rid="SD3">S7B-D</xref>). Furthermore, introduction of truncated APC induced enrichment of gene signatures representing transit amplifying (TA) cells and stem-like cells, while secretory cell profiles and the TINC signature were significantly reduced (<xref ref-type="fig" rid="F6">Figures 6C</xref> and <xref ref-type="fig" rid="F6">6D</xref>)<sup><xref ref-type="bibr" rid="R33">33</xref></sup>. Single cell analysis revealed that introduction of an <italic>APC</italic> mutation shifted HUB040 cell identity and composition, as shown by an increased fraction of WNT-high cells and a reduced fraction of cells expressing the TINC signature (<xref ref-type="fig" rid="F6">Figures 6E, 6F</xref> and <xref ref-type="supplementary-material" rid="SD3">S7E-G</xref>). These alterations were not compatible with efficient growth, as HUB040<sup>APC-/-</sup> organoids were outcompeted by HUB040<sup>APCwt</sup> organoids during co-culture (<xref ref-type="fig" rid="F6">Figure 6G</xref>). We conclude that <italic>APC</italic> mutations, in context of a <italic>BRAF/RNF43</italic>-mutant tumour background, interfere with intra-epithelial niche formation that is otherwise facilitated by mutant <italic>RNF43</italic>.</p><p id="P16">We hypothesized that adjustable levels of WNT signalling are vital for <italic>BRAF/RNF43-</italic>mutant tumour self-organising capacity. Indeed, constitutive pharmacological activation of WNT signalling (CHIR99021) was not tolerated by HUB040 organoids (<xref ref-type="fig" rid="F6">Figure 6H</xref>). Furthermore, HUB040 organoids treated with WNT inhibitors for 24 and 48 hours (<xref ref-type="supplementary-material" rid="SD3">Figures S7H-J</xref>) revealed an incremental downregulation of proliferative, stem and TA signatures and an increase in differentiation signatures, including TINC (<xref ref-type="fig" rid="F6">Figures 6C and 6D</xref>). In line with these findings, the number and brightness of TINC reporter cells in HUB040 increased upon WNT inhibitor treatment (<xref ref-type="fig" rid="F6">Figures 6I</xref> and <xref ref-type="supplementary-material" rid="SD3">S7K</xref>). Thus, although <italic>BRAF/RNF43-mutant</italic> mucinous cancers are wired towards lower levels of WNT signalling that are optimal to facilitate secretory differentiation, a threshold of WNT signalling in a subset of cancer cells is still required to prevent terminal differentiation and maintain self-renewal of proliferative cells (<xref ref-type="fig" rid="F6">Figure 6J</xref>).</p></sec></sec><sec id="S9" sec-type="discussion"><title>Discussion</title><p id="P17">Self-organisation principles promote tumour progression in CRC<sup><xref ref-type="bibr" rid="R34">34</xref>–<xref ref-type="bibr" rid="R41">41</xref></sup>, but thus far the underlying genetic driver events remained poorly understood. In this study, we show that <italic>RNF43</italic> mutations facilitate the generation of TINCs, tumour-intrinsic NDRG1<sup>high</sup>/VEGFA<sup>high</sup> niche cells that secrete essential growth factors to drive proliferation and survival of adjacent stem-like cancer cells. Despite their differentiated, non-proliferative phenotype, TINCs retain phenotypic plasticity and can give rise to full-blown tumour structures.</p><p id="P18">Different from classical <italic>APC</italic> mutations that promote uniform high WNT signalling and endow tumour cells with stem-like properties, we find that mutant <italic>RNF43</italic> permits for tuneable WNT activity, which enables tumour cells to pick diverging phenotypic states. Accordingly, <italic>RNF43</italic> mutations drive a growth state that relies on interactions between dividing and non-dividing cancer cell populations (<xref ref-type="fig" rid="F6">Figure 6K</xref>). This role of mutant <italic>RNF43</italic> is reminiscent of the concomitant hyperplasia of stem cells and Paneth niche cells induced by co-deletion of <italic>Rnf43/Znrf3</italic> from the mouse small intestine<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. In human colon cancer development, however, <italic>RNF43</italic> mutations arise after tumour-initiating <italic>BRAF</italic> mutations<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R32">32</xref></sup>. Consistently, our results indicate that <italic>RNF43</italic> mutations are crucial for metastatic spread, but not for tumour initiation. As both niche independency and phenotypic plasticity correlate with metastatic capacity in CRC<sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41">41</xref></sup>, it is tempting to speculate that mutant <italic>RNF43</italic>-mediated TINC formation is a prerequisite for metastasis to distant organs. In line with this assumption, we find that TINC profiles are enhanced in metastatic samples of mucinous human CRC.</p><p id="P19">Strikingly, introduction of <italic>APC</italic> mutations in a <italic>BRAF/RNF43</italic>-mutant context suppresses TINC formation and is not beneficial for growth of this tumour subtype, indicating that cancer driver activity of WNT mutations relies on a specific mutational context. Furthermore, the dependence of <italic>BRAF</italic>/<italic>RNF43</italic>-mutant tumours on adjustable WNT signalling for establishing a tumour-intrinsic niche offers an opportunity for pharmacological interference. While constitutive enhancement of WNT signalling in these tumours precludes niche formation and growth factor self-sufficiency, inhibition of WNT pushes terminal differentiation and stem cell depletion. Notwithstanding the clear regulatory role of WNT, other pathways may play a role in TINC formation. <italic>RNF43</italic> truncating mutations were recently linked to activation of the PI3K-Akt-mTOR pathway<sup><xref ref-type="bibr" rid="R42">42</xref></sup>, which also mediates activation of cellular programs linked to glycolysis and hypoxia<sup><xref ref-type="bibr" rid="R43">43</xref></sup>, as well as Goblet and Paneth cell differentiation in the mouse intestine and human intestinal organoids<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R44">44</xref>,<xref ref-type="bibr" rid="R45">45</xref></sup>.</p><p id="P20">Additionally, we demonstrate that <italic>RNF43</italic> mutations are causative to a mucinous CRC phenotype. How excessive mucus production links to cancer development and metastasis formation remains incompletely understood<sup><xref ref-type="bibr" rid="R46">46</xref></sup>, although roles in immune evasion, growth factor trapping and chemoprotection were proposed<sup><xref ref-type="bibr" rid="R47">47</xref></sup>. We expect that formation of an intra-tumoral pro-metastatic mucinous niche is relevant for other <italic>RNF43</italic>-mutant human cancers with mucinous histology, including intraductal mucinous carcinoma of the pancreas and mucinous ovarian cancer<sup><xref ref-type="bibr" rid="R48">48</xref>–<xref ref-type="bibr" rid="R50">50</xref></sup>.</p><p id="P21">In summary, our study demonstrates that genetic correction of putative driver genes in patient-derived organoids is a powerful approach to examine the mechanistic role of these mutations in an advanced human cancer context. Our findings predict that <italic>RNF43</italic>-mediated tumor-intrinsic niche formation is a broad concept in cancer biology, and that a comprehensive understanding of the pathways and mechanisms underlying tumour niche self-organization are likely to provide insights that may be harnessed to help limit disease progression and metastatic recurrence.</p></sec><sec id="S10" sec-type="methods"><title>Methods</title><sec id="S11"><title>Patient material</title><p id="P22">The collection of colorectal tissue for the generation of healthy colon and CRC organoids was performed according to the guidelines of the European Network of Research Ethics Committees (EUREC) following European, national and local law. In all cases, patients signed informed consent after ethical committees approved the study protocols. Organoids identified by HUB codes <italic>HUB-02-B2-040</italic> (HUB040, CRC) and <italic>HUB-02-A2-040</italic> (HUB040N, normal colon) are catalogued at <ext-link ext-link-type="uri" xlink:href="https://huborganoids.nl/">https://huborganoids.nl/</ext-link> and can be requested at info@huborganoids.nl. Distribution to third (academic or commercial) parties will have to be authorized by the Biobank Research Ethics Committee of the University Medical Center Utrecht (TCBio) at request of Hubrecht Organoid Technology (HUB). P26T (CRC) was established in a previous study.<sup><xref ref-type="bibr" rid="R13">13</xref></sup></p></sec><sec id="S12"><title>Organoid culture</title><p id="P23">Healthy colon organoids and CRC organoids were cultured according to previous protocols<sup><xref ref-type="bibr" rid="R13">13</xref></sup>. In short, organoids were cultured in drops of Matrigel (Corning) or BME (R&amp;D systems), and the medium was refreshed every two or three days. CRC organoids were passaged using TrypLE Express (Life Technologies) incubation at 37 °C. Healthy colon organoid were passaged using mechanical shearing (pipetting). Healthy colon organoids were cultured in advanced DMEM/F12 medium (Invitrogen), supplemented with 1% Penicillin/Streptomycin (P/S, Lonza), 1% Hepes buffer (Invitrogen), 1% Glutamax (Invitrogen), 1x B27 (Invitrogen), 10 mM Nicotinamide (Sigma-Aldrich), 1.25 mM N-acetylcysteine (Sigma-Aldrich), 50 ng/mL EGF (PeproTech), 500 nM TGF-b type I receptor inhibitor A83-01 (Tocris), 10 μM P38 inhibitor SB202190 (Sigma-Aldrich), 50% Wnt3a-CM (homemade) or 1% surrogate WNT-CM (homemade)<sup><xref ref-type="bibr" rid="R53">53</xref></sup>, 10% Noggin-CM (homemade), 20% Rspo1-CM (homemade) and 100 μg/mL Primocin (Invitrogen) (full medium). Colorectal carcinoma organoids were cultured in medium without EGF, WNT and RSPO (CRC medium), unless stated otherwise. <italic>RNF43-corrected</italic> (RC), non-corrected (NC) HUB040 clones were maintained in full HCO medium to prevent negative selection against growth factor dependence.</p></sec><sec id="S13"><title>CRISPR strategy and design</title><p id="P24">To correct the <italic>RNF43</italic> P441fs mutation back to wildtype, HUB040 organoids were electroporated with a single stranded HDR template (ss-oligo) and Cas9-gRNA. The ss-oligo was designed according to previously established optimal rules.<sup><xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R55">55</xref></sup> Briefly, the <italic>RNF43</italic> mutation in HUB040 is a five base pair duplication, which was corrected in the template. The template was an asymmetric template oligo complementary to the non-target strand overlapping the Cas9 cut site with 36 bp extension on the PAM-distal side, and with a 91-bp extension on the PAM-proximal side of the break. The ss-oligo was ordered at Integrated DNA Technologies with phosphorothioate modifications of the last two nucleotide bonds at the 3’ and 5’ end (sequence:</p><p id="P25">TATGCACAAGGCTGGGGAATGAGCCACCTCCAATCCACCTCACAGCACCCTGCTG CTTGCCCAGTGCCCCTACGCCGGGCCAGGCCTCCAGACAGCAGTGGATCTGGAGA AAGCTATTGCACAGAACGC). A gRNA was chosen using the Benchling tool (<ext-link ext-link-type="uri" xlink:href="https://benchling.com">https://benchling.com</ext-link>) that created a double stranded break close to the mutation (sequence: CCAGATCCACTGCTGTCAGG) and cloned in pSpCas9(BB)-2A-Puro (Addgene, 48139).</p><p id="P26">APC mutations were introduced by targeting the mutation cluster region (MCR) in the <italic>APC</italic> gene using previously reported gRNA (sequence: TACATCTGCTAAACATGAG).<sup><xref ref-type="bibr" rid="R31">31</xref></sup></p><p id="P27">Reporter targeting vector was generated by altering <italic>HR180-LGR5-iCT</italic> plasmid (Addgene #129094) into a plasmid compatible with insertion of homology arms using golden-gate cloning<sup><xref ref-type="bibr" rid="R56">56</xref></sup>. iCaspase-T2A-tdTomato sequence was removed and swapped for mNeonGreen-NLS using a combination of Q5® High-Fidelity DNA Polymerase and the In-Fusion HD Cloning kit (Takara). Final targeting vector was generated by insertion of homology arms (~600bp each) flanking the targeted region downstream of NDRG1 to obtain the NDRG1-specific <italic>IRES-mNeonGreen-NLS-WPRE-bGHpA-EF1-Ruby-T2A-Puro-SV40pA</italic> targeting plasmid. gRNAs were cloned into pSpCas9(BB)-2A-Puro using golden gate cloning (sequence: CCGGACTCTGATCTCTGTAG)).)).</p></sec><sec id="S14"><title>Electroporation</title><p id="P28">Organoid electroporation was performed as previously described<sup><xref ref-type="bibr" rid="R57">57</xref></sup>. Briefly, organoids were grown in antibiotic-free medium including 10 μM Y-27632 (Selleck chemicals) for two days before electroporation. 24 hours before electroporation, 1.25% DMSO was added to the culture medium. For electroporation, the NEPA21 electroporator was used with the configuration reported by Fujii et al.<sup><xref ref-type="bibr" rid="R57">57</xref></sup>. For <italic>RNF43</italic> correction and generation of TINC-reporter, 5 μg of Cas9-gRNA and 5 μg template were transfected. For other CRISPR targeting, 10 μg of Cas9-gRNA was transfected. Organoids were recovered for two days by adding medium supplemented with 10 μM Y-27632. From five days post-electroporation organoids were grown in full medium. For CRISPR-engineered organoids, single clones were established by manual picking of individual organoids derived from single cells and genotyped. Reporter lines were selected by puromycin treatment and sorted for the constitutive mRuby fluorophore and single cell derived clones were picked manually and genotyped.</p></sec><sec id="S15"><title>Genotyping</title><p id="P29">For genotyping of genome-edited organoids, genomic DNA was isolated using QIAamp DNA micro kit (Qiagen). PCR amplification performed using using GoTaq Flexi DNA polymerase (Promega) and products were loaded on an agarose gel. Gel fragments of expected sizes were isolated using QIAquick gel extraction kit (Qiagen) and sequenced by Sanger sequencing. Knockout and Knockin efficiencies were determined using the TIDE<sup><xref ref-type="bibr" rid="R58">58</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://shinyapps.datacurators.nl/tide/">http://shinyapps.datacurators.nl/tide/</ext-link>) and TIDER<sup><xref ref-type="bibr" rid="R59">59</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://shinyapps.datacurators.nl/tider/">http://shinyapps.datacurators.nl/tider/</ext-link>) tools respectively. Manual verification of genotypes for clonal lines was done in Benchling.</p><p id="P30">HUB040 NDRG1-IRES-mNeon clonal organoid lines were genotyped to confirm homozygous integration of the knock-in construct using gel electrophoresis of PCR products.</p><p id="P31">Primers used for genotyping are listed in <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 1</xref>.</p></sec><sec id="S16"><title>Whole-Genome Sequencing and mapping</title><p id="P32">Genomic DNA of naïve HUB040 and clonal organoid lines was isolated using QIAamp DNA micro kit (Qiagen) and DNA libraries for Illumina sequencing were generated by using standard protocols (Illumina) Libraries were sequenced on a NovaSeq 6000 S4 platform with 2 x 150 bp read length to 30 times base coverage.</p><p id="P33">Sequencing reads were mapped against human reference genome GRCh38 by using Burrows-Wheeler Aligner v0.7.17 mapping tool<sup><xref ref-type="bibr" rid="R60">60</xref></sup> with settings ‘bwa mem -c 100 -M’. Sequence reads were marked for duplicates by using Sambamba<sup><xref ref-type="bibr" rid="R61">61</xref></sup> v0.6.8 and sequence read quality scores were recalibrated with GATK<sup><xref ref-type="bibr" rid="R62">62</xref></sup> BaseRecalibrator v2.7.2. CNVs detection was performed with Control-FREEC<sup><xref ref-type="bibr" rid="R63">63</xref></sup> v11.56. Full pipeline description and settings are also available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/UMCUGenetics/IAP">https://github.com/UMCUGenetics/IAP</ext-link>.</p></sec><sec id="S17"><title>Mutation calling and filtering</title><p id="P34">Mutation calling and filtering was performed on multi-sample vcfs generated by IAP using HaplotypeCaller from GATK v.4.1.3.0. GATK’s VariantFiltration was used for variant quality evaluation with options: “--filter-expression ‘QD &lt; 2.0’ --filter-expression ‘MQ &lt; 40.0’ --filterexpression ‘FS &gt; 60.0’ --filter-expression ‘HaplotypeScore &gt; 13.0’ --filter-expression ‘MQRankSum &lt; -12.5’ --filter-expression ‘ReadPosRankSum &lt; -8.0’ --filter-expression ‘MQ0 &gt;= 4 &amp;&amp; ((MQ0 / (1.0 * DP)) &gt; 0.1)’ --filter-expression ‘DP &lt; 5’ --filter-expression ‘QUAL &lt; 30’ --filter-expression ‘QUAL &gt;= 30.0 &amp;&amp; QUAL &lt; 50.0’ --filter-expression ‘SOR &gt; 4.0’ -filter-name ‘SNP_LowQualityDepth’ --filter-name ‘SNP_MappingQuality’ --filter-name ‘SNP_StrandBias’ --filter-name ‘SNP_HaplotypeScoreHigh’ --filter-name ‘SNP_MQRankSumLow’ --filter-name ‘SNP_ReadPosRankSumLow’ --filter-name ‘SNP_HardToValidate’ --filter-name ‘SNP_LowCoverage’ --filter-name ‘SNP_VeryLowQual’ --filter-name ‘SNP_LowQual’ --filter-name ‘SNP_SOR’ -cluster 3 -window 10”.</p><p id="P35">Subsequently, SNPEffFilter<sup><xref ref-type="bibr" rid="R64">64</xref></sup>, SNPSiftDbnsfp (database dbNSFP3.2a<sup><xref ref-type="bibr" rid="R65">65</xref></sup>;, GATK VariantAnnotator (database COSMIC v.89), and SNPSiftAnnotate (database GoNL release 5) were used for variant annotation.</p><p id="P36">Finally, to obtain catalogues of high-quality somatic mutation calls, we applied post-processing filtering steps, per sample, as described below (all scripts are available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/ToolsVanBox/SMuRF">https://github.com/ToolsVanBox/SMuRF</ext-link>).</p><p id="P37">Briefly, only variants were considered if present on autosomal chromosomes, passed VariantFiltration with a GATK phred-scaled quality score ≥ 100, had a base coverage of at least 10X, had a mapping quality (MQ) score of 60, did no overlap with single nucleotide polymorphisms (SNPs) in the Single Nucleotide Polymorphism Database v146 and a panel of unmatched normal human MSC and fetal genomes (BED-file available upon request), had a GATK genotype score (GQ) of 99 (indel/sbs in clonal sample, or indel in paired control) or higher than 10 (sbs in paired control), had a variant allele frequency (VAF) of &gt;=0.1 to exclude <italic>in vitro</italic> accumulated mutations.</p></sec><sec id="S18"><title>Identification of driver mutations</title><p id="P38">Single base substitutions or indels were considered as driver mutations when they have a MQ of 30, a minimal base coverage of 10x, had a VAF equal or higher than 0.1, or present in driver genes COSMIC cancer gene consensus (version of 9/5/2019), were also annotated as missense, frameshift, stop-gain, insertion or deletion, had either a high or moderate expected effect as annotated by SnpEff, and were not present in the Single Nucleotide Polymorphism Database v146 and a panel of unmatched normal human MSC and fetal genomes (BED-file available upon request). Oncoplot (<xref ref-type="supplementary-material" rid="SD3">Figure S1A</xref>) was generated with the ComplexHeatmap<sup><xref ref-type="bibr" rid="R66">66</xref></sup> v2.12.0 package from Bioconductor.</p><p id="P39">Structural variant and chromosomal copy-number alteration calling was performed using the GRIDSS-purple-linx<sup><xref ref-type="bibr" rid="R67">67</xref></sup> pipeline developed at the Hartwig Medical Foundation.</p></sec><sec id="S19"><title><italic>In vivo</italic> subcutaneous tumorigenesis</title><p id="P40">Animal experiments were approved by the Competent Authority, The Netherlands (License number AVD115002016614), which is advised by the Animal Ethics Committee. Animal work protocol (614-1-22) was approved by the Animal Welfare Body and were performed in accordance with the Dutch Law on Animal Experiments and the European Directive 2010/63/EU. Healthy 8–10 week old 25–30 g male <italic>NOD.Cg-Prkdc<sup>scid</sup> Il2rg<sup>tm1Wjl</sup>/SzJ</italic> (NSG) mice were supplied by Charles River. Animals were randomly allocated in groups of three mice into individually ventilated cages. Animals were kept at room temperature under 12 hours light/dark cycles and received standard chow pellets and water ad libitum. HUB040 organoids were dissociated five days after passaging into single-cells by TrypLE Express incubation for 5 min at 37 °C. A cell-matrigel (1:1) suspension was prepared with 5 × 10<sup><xref ref-type="bibr" rid="R6">6</xref></sup> cells/mL. Using a 1 mL syringe and 25G 0.5 × 16 mm needles, 100 μl of the suspension were subcutaneously injected into the right flank of animals. Animal welfare was monitored by physical appearance, behaviour, and body weight. Animals were sacrificed when the tumour volume (V) reached 1.5 mm<sup><xref ref-type="bibr" rid="R3">3</xref></sup>, as measured by V = 1/2 × (smaller diameter<sup><xref ref-type="bibr" rid="R2">2</xref></sup> × larger diameter). Tumour tissue was harvested for further immunohistochemical analyses. Sample sizes are outlined in the figure legends. Mice were randomly assigned to experimental groups. No blinding method was used for injection. No animals were excluded from downstream analysis.</p></sec><sec id="S20"><title>Orthotopic implantation in the caecum of NSG mice</title><p id="P41">In order to evaluate the tumourigenic capacity of the organoids, murine orthotopic caecum-implantation model<sup><xref ref-type="bibr" rid="R17">17</xref></sup> was used as described in animal work protocol (614-1-22). In summary, day before implantation, HUB040 organoids were dissociated into single cells and 2.5 × 10<sup><xref ref-type="bibr" rid="R5">5</xref></sup> cells were plated in 10 μL drops of neutralized Rat Tail High Concentrated Type I Collagen (Corning, C3867). Cultures were allowed to recover overnight at 37 °C, 5% (vol/vol) CO2. NSG mice were treated with a s.c. dose of Carprofen (5 mg/kg, Rimadyl™) 30 min before surgery and were subsequently sedated by using isoflurane inhalation anesthesia [~2% (vol/vol) isoflurane/O2 mixture]. The caecum was exteriorized through a midline abdominal incision and a single collagen drop containing organoids was surgically transplanted in the cecal submucosa. Carprofen was administrated s.c. post 24 hour surgery. Animal welfare was monitored by physical appearance, behaviour, and body weight. Power analyses were carried out prior to experiments being carried out to determine the minimum number of animals required for each experiment. These analyses were informed by previous and / or preliminary experiments. Animals were house vested in groups of four. Every group (i.e. cage) contained mixture of mice transplanted with both organoid genotypes. No animals were excluded from downstream analysis. The biotechnician was blinded to the group allocation of the animals during the experiment.</p></sec><sec id="S21"><title>Immunohistochemistry (IHC)</title><p id="P42">Mouse tissues with or without organoid-initiated tumours/metastases were fixed in 4% formaldehyde solution and paraffin embedded. Sections of 4 μm thickness were made. Prior to the staining, tissue sections were deparaffinized and rehydrated. Endogenous peroxidase activity was blocked with 1.5% hydrogen peroxide for 30 min. Heat-induced antigen retrieval was carried out using citrate buffer pH6.0 for 20 min, followed by the cooling of tissue sections for 20 min. Sections were incubated overnight at 4 °C with primary antibodies (anti-hNucleoli clone NM95, Abcam (ab190710) 1:1000 and anti-Mucin2 clone (H-300), Santa Cruz (sc-15334), 1:100) diluted in PBS with 0.1% Sodium azide and 3% BSA. The next day, sections were washed three times with 0.05% Tween-PBS solution for 5 min, followed by a 1 hour incubation with the HRP-conjugated secondary antibody. Subsequently, sections were washed three times with 1× PBS for 5 min and developed with 3,3’-Diaminobenzidine (DAB) chromogen for 10 min at room temperature in the dark. Sections were rinsed under running tap water for 10 min and counterstained with hematoxylin, followed by dehydration and mounting.</p><p id="P43">Stainings were scanned using NanoZoomerXR whole slide scanner (Hamamatsu) at 40X magnification, with a resolution of 0.25 μm/pixel. Quantification of the scans was performed using QuPath program analysis program<sup><xref ref-type="bibr" rid="R68">68</xref></sup>. Target of interest (tumour or distinct immune populations) was quantified using QuPath’s Trained Pixel classification command that allows an automated recognition of background, tissue (hematoxylin) and DAB staining areas. The percentage of target of interest area was then calculated by using the following formula: DAB area / (DAB + tissue− background area) * 100.</p></sec><sec id="S22"><title>Reconstitution assays using growth factor and drug treatments</title><p id="P44">Single cells from organoid were harvested using TrypLE incubation at 37 °C. Cells were filtered through a 40 μm nylon cell strainer (Falcon). Cells were counted and seeded in a 1*10<sup><xref ref-type="bibr" rid="R6">6</xref></sup> cells / mL dilution in Matrigel/BME. Cultures were incubated in standard culture medium with indicated additions/depletions of factors and drugs, which was replenished every 2-3 days. After seven days, brightfield images were taken using an EVOS imaging system and organoids were split 1:2 similar as mentioned before, after which outgrowth was monitored again for seven days. Quantitative viability assays were performed by CellTiter-Glo® (Promega) or Alamar Blue® (Thermo Fisher) according to manufacturer instructions. Pictures are shown for a representative experiment, which was performed at least three times. Normalized viability data was combined from multiple experiments and two or three technical replicates per experiment.</p></sec><sec id="S23"><title>Bulk RNA sequencing</title><p id="P45">Organoids were lysed in RLT lysis buffer (Qiagen) + 1% β-mercapto-ethanol; seven days after passaging. Biological triplicates were employed that were passaged and lysed at separate moments. For the LGK-974 experiments, organoids were treated with 100 nM LGK-974 or a DMSO volume control for 24 or 48 hours prior to lysis. RNA was obtained using the Qiagen QiaSymphony SP (Qiagen) according to the manufacturer’s protocol. Library prep was performed using Truseq RNA stranded polyA (Illumina). Libraries were sequenced on an Illumina NextSeq2000 platform with 1x50bp reads. Single-end RNASeq reads were processed using the UMCU RNASeq pipeline (v2.3.0) with default settings. Read quality was assessed by FastQC (0.11.4) followed by splice-aware alignment against the human reference genome (GRCh38) with STAR<sup><xref ref-type="bibr" rid="R69">69</xref></sup> (2.4.2a). RNA expression quantification was performed with htseq-count (0.6.0) in reverse-stranded mode. Differential gene expression analysis was performed with the DESeq2<sup><xref ref-type="bibr" rid="R70">70</xref></sup> (1.22.2) R package. In each comparison, genes were selected with an absolute fold-change &gt; 1.5 and p adjusted &lt; 0.05. Generation of heatmaps and scatterplots was done in using the pHeatmap and ggplot2 R packages.</p></sec><sec id="S24"><title>GSEA and gene signatures</title><p id="P46">Gene set enrichment analyses (GSEA) were performed using the Broad Institute GSEA tool (software.broadinstitute.org/gsea/index.jsp) with default settings, including permutation by gene sets. HALLMARK genesets were derived from the Molecular Signatures Database.<sup><xref ref-type="bibr" rid="R71">71</xref></sup> Geneset for REG4<sup>+</sup> deep crypt secretory cells (DCSs) was defined as human orthologues (identified by bioDBnet) of the &gt;2 fold upregulated genes with a p-value &lt; 0.05 in Reg<sup>+</sup> cells compared to Lgr5<sup>+</sup> cells that were previously reported.<sup><xref ref-type="bibr" rid="R18">18</xref></sup> Gene sets for human colon specific cell types were derived from a published single-cell transcriptome study (Wang et al. <xref ref-type="supplementary-material" rid="SD3">table S2</xref>).<sup><xref ref-type="bibr" rid="R19">19</xref></sup> Genesets for HUB040 single cell clusters were defined by marker gene analysis using the ‘FindAllMarkers’ command in Seurat comparing one cluster to all other clusters using a wilcox test. Threshold for adjusted p-value was set at p &lt; 0.05. The WNT signature was reported previously by Van der Flier <italic>et al</italic>.<sup><xref ref-type="bibr" rid="R52">52</xref></sup></p><p id="P47">For the analysis of secretory genes, a list of secreted proteins was downloaded from human protein atlas (“Secreted proteins predicted by MDSEC”)<sup><xref ref-type="bibr" rid="R72">72</xref></sup>. Downregulated secretory genes were defined as: significantly downregulated in at least three comparisons and not upregulated in the other comparison (RC1 vs HUB040, RC2 vs HUB040, RC1 vs NC1, RC2 vs NC1)</p></sec><sec id="S25"><title>Single cell RNA sequencing and analysis</title><p id="P48">Single cells from organoid were harvested using TrypLE incubation at 37 °C, seven days after passaging. Cells were filtered through a 40 μm nylon cell strainer (Falcon). scRNA-seq was performed according to the Sort-seq protocol<sup><xref ref-type="bibr" rid="R73">73</xref></sup>. Libraries were sequenced on an Illumina NextSeq500 at paired-end 60- and 26-bp read length and 75,000 reads per cell.</p><p id="P49">Reads were mapped to the hg38 reference genome. Analysis was performed with the R-package Seurat<sup><xref ref-type="bibr" rid="R74">74</xref></sup> (4.0.4). Cells with 400-50000 unique features and 1000-7000 total transcript counts were included in the analysis. Scores for gene signature expression were calculated using the AddModuleScore function.</p><p id="P50">Signature enrichment in marker gene lists was determined using the Enrichr tool<sup><xref ref-type="bibr" rid="R75">75</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://maayanlab.cloud/Enrichr/">https://maayanlab.cloud/Enrichr/</ext-link>).</p><p id="P51">To analyse fraction of TINCs in <italic>RNF43</italic>-corrected and non-corrected clones, cells were filtered according to previously mentioned settings and for each cell a module score for the original TINC signature was calculated. Cells with a module score &gt; 0.61 were scored as TINC, which corresponded to 16% of cells in the HUB040 naïve sample (which was the fraction of cells mapping to cluster 1 in the original analysis). Data was plotted using ggplot2.</p><p id="P52">To validate the TINC signature in a human cohort, published RNAseq data of tumour epithelial cells of colorectal cancer patients were used<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. Twenty <italic>RNF43</italic> wildtype patients from iCMS2 cohort based on single-cell RNA sequencing and inferred CNV result and four <italic>RNF43</italic> mutant patients were selected. After selecting patients, supervised clustering using 154 TINC signature genes was performed with batch correction using harmony algorithm<sup><xref ref-type="bibr" rid="R76">76</xref></sup> to remove patient specificity. Differential gene expression analysis was performed using the ‘FindAllMarkers’ command in Seurat with logistic regression framework.</p></sec><sec id="S26"><title>TCGA data analysis</title><p id="P53">Signature scores for indicated gene sets were calculated for each samples as log2 Z-score over the total TCGA Colon Adenocarcinoma set (rpkm values of 382 samples - cbcoad) using the R2 genomic analysis platform (<ext-link ext-link-type="uri" xlink:href="https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?open_page=login">http://r2.amc.nl</ext-link>). TINC signature was determined as the top 25 marker genes for cluster 1 in HUB040 (from Seurat marker gene analysis). <italic>RNF43</italic> mutation status was determined by combining the list of <italic>RNF43</italic> mutant TCGA samples (derived from C-bioportal) combined with results of re-analysis by Gianakkis <italic>et al</italic>.<sup><xref ref-type="bibr" rid="R32">32</xref></sup> calling additional mutations that were falsely labelled as polymerase slipping errors in the original TCGA analysis.<sup><xref ref-type="bibr" rid="R32">32</xref></sup> CMS classifications were derived from the Colorectal Cancer Subtyping Consortium (CRCSC)<sup><xref ref-type="bibr" rid="R77">77</xref></sup>, samples without CMS label have been left out of the analysis. Classification as mucinous was derived from Cancer Type in cbioportal (mucinous adenocarcinoma of colon and rectum). “High and low WNT” was defined as the upper and lower quartile of the Z-scores for the intestinal WNT/TCF signature as reported by Van der Flier <italic>et al</italic>.<sup><xref ref-type="bibr" rid="R52">52</xref></sup>.</p></sec><sec id="S27"><title>Immunofluorescence</title><p id="P54">For staining of Mucin2, organoids were seeded in 15-well IBIDI angiogenesis chambers during passaging and fixed 7-12 days later in 4% paraformaldehyde (PFA) (Sigma-Aldrich) for 60 min at room temperature. The fixation was quenched using 0.05 M NH4Cl and cells were permeabilised with PBD0.2T (48,5mL PBS, 1mL 10%Triton, 0,5mL DMSO and 0,5g BSA) for 20 min at room temperature. The organoids were incubated with primary antibodies diluted</p><p id="P55">in PBD0.2T at 4 °C overnight. Washes were performed with PBD0.2T after which secondary antibodies were incubated for 3h at room temperature. Stained organoids were mounted using IBIDI mounting medium.</p><p id="P56">For other stainings, organoids were cultured as usual. 7-12 days after passaging, matrix was removed using dispase (Invitrogen) and organoids were transferred to 8-well IBIDI imaging slide. Fixation, permeabilisation and antibody staining were performed inside the imaging slide, as indicated above, except for primary antibody incubations were performed for one hour at room temperature. Stained organoids were mounted using IBIDI mounting medium.</p><p id="P57">The following antibodies and dyes have been used for immunofluorescence: Mouse-anti-Mucin2 (sc-515032, Santa Cruz, 1:200), Mouse-anti-β-catenin (610154, BD Transduction Laboratories, 1:200), Rabbit-anti-KI67 (ab15580, Abcam, 1:200), Goat-anti-Mouse-Alexa-488 (A11029, Invitrogen, 1:600) Goat-anti-Rabbit-Alexa-647 (A21245, Invitrogen, 1:600), Phalloidin-Alexa-647 (8940S, CST, 1:200) and Dapi (D9542, Sigma, 1:1.000). Images were acquired with a Zeiss LSM700 confocal microscope.</p><p id="P58">Image processing was performed using FIJI (2.3.0). Nuclear β-catenin and TINC-reporter intensity were quantified using the StarDist plugin (0.8.3)<sup><xref ref-type="bibr" rid="R78">78</xref></sup> with the Dapi staining used for single nucleus segmentation. Data was analysed and plotted in R.</p></sec><sec id="S28"><title>Hybrid organoid co-culture, time-lapse imaging and analysis</title><p id="P59">The protocol on generating hybrid organoid co-cultures has been described previously<sup><xref ref-type="bibr" rid="R20">20</xref></sup>. In short: HUB040 naïve organoids were transduced with mCherry tagged H2B constructs and HUB040 RC2 organoids with mNeon green tagged H2B constructs and selected by FACS sorting. Six days post splitting, both lines were starved in CRC medium for 24 hours and at day 7 broken up into small clumps of cells that were mixed in 1:1 ratio. Cells were concentrated by centrifugation, resuspended in a small volume of CRC medium and incubated at 37 °C for 30 min Cell aggregates were plated in 10 μL BME droplets in an 18 Well μ-Slide (IBIDI #81811). Three days after plating, time-lapse microscopy was performed on an inverted LSM880 Fast AiryScan scanning confocal microscope (Zeiss) using LSM scanning mode with a 488nm Argon-laser and 561nm Diode-laser, equipped with a 20X dry immersion objective (Objective Plan-Apochromat 20x/0.8 M27, Zeiss). Cells were kept in CRC medium at 37°C under 5% CO2 for the full duration of the experiment. Images were acquired with a Z-interval of 5μm covering the full volume of the organoid and time-interval of one hour for a total duration on 60 hours. Time-lapse images were processed and analysed following a previously described pipeline in which depth-encoded movies were generated in which cell divisions and cell dead events were scored<sup><xref ref-type="bibr" rid="R79">79</xref></sup>. The cell death / mitosis ratio was calculated as a proxy for organoid survival. Cell numbers at the start of time-lapse were counted using Imaris software (Andor version 9.9.1). Videos and snapshots of 3D-reconstructed representative organoids were made in Imaris.</p></sec><sec id="S29"><title>Flow cytometry analysis and sorting of organoids</title><p id="P60">Single cells from organoid were harvested using TrypLE incubation at 37 °C. Cells were filtered through a 40 μm nylon cell strainer (Falcon) and live-cells were measured at a FACS Celesta with FACS Diva software (BD). The following fluorescent channels were used: BB515 for mNeon, PE-CF594 for mRuby and PE-Cy5 for Alexa-647 labelled Edu.</p><p id="P61">EdU incorporation assays were performed by culturing organoids in CRC medium containing 10 μM EdU for 16 hours to cells, after which single cells were harvested, fixed in 4% PFA and EdU-labeling was performed according to manufacturer instructions (Click-iT EdU Cell Proliferation Kit for Imaging, Thermo Fisher).</p><p id="P62">Sorting of TINC-reporter populations was performed using a FACS Aria III machine (BD) Populations were gated for viable single cells which were divided in three equal populations of 20-30% of the total based on mNeon histogram (example in <xref ref-type="supplementary-material" rid="SD3">Figure S5A</xref>). Sorted cells were directly lysed in RLT lysis buffer (Qiagen) for RNAseq analysis, or taken in culture for organoid reconstitution, by seeding in a 1x10<sup><xref ref-type="bibr" rid="R6">6</xref></sup> cells / mL dilution in BME.</p><p id="P63">Gated single cells were analysed in FlowJo (version 10.6.1).</p></sec><sec id="S30"><title>Western blot</title><p id="P64">Organoids were collected in Cell Recovery Solution (Corning), incubated for 20 min on ice and subsequently lysed in RIPA buffer containing protease and phosphatase inhibitors. Lysates were boiled in 1x SDS sample buffer and ran on a pre-casted SDS-page gel (Mini protean, BIORAD). Gels were transferred to a Immobilon-FL PVDF membranes (Millipore), which was blocked for 1 hour at room temperature in 1:1 ratio Odyssey blocking buffer (LI-COR): PBS, and stained against APC (sc-7930, Santa Cruz, 1:1.000) and Actin (691001, MP, 1:10.000) overnight at 4 °C. Blots were stained with secondary antibodies IRDye-680 goat anti-rabbit (926-32221, LI-COR, 1:10.000) and IRDye-800 goat anti-mouse (925-68070, LI-COR, 1:10.000) for 1 hour at room temperature in the dark. The Typhoon (GE Healthcare) infrared imaging system was used for immunoblot analysis.</p></sec><sec id="S31"><title>RT-qPCR</title><p id="P65">Organoids, seven days after passaging, or FACS-sorted cell populations were lysed in RLT lysis buffer (Qiagen) + 1% β-mercapto-ethanol and RNA was purified using the RNeasy kit (Qiagen) according to manufacturer’s protocol. RNA was used as a template for cDNA production using the iScript™ cDNA Synthesis Kit (Biorad) according to the manufacturer’s protocol. The synthesized cDNA was subsequently used in a qRT–PCR using IQ SYBR green mix (Biorad) according to the manufacturer’s protocol. Used primers are listed in <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref></p><p id="P66">Expression of WNT target genes was corrected against house-keeping gene <italic>GAPDH</italic> and normalized to the control.</p></sec><sec id="S32"><title>APC competition assay</title><p id="P67">HUB040 and HUB040<sup>APC-/-</sup> organoids were split into single cells, counted and seeded in a 1:1 ratio. Mixed organoid populations were passaged once a week, and during each passage, genomic DNA was harvested for genotyping the fraction of <italic>APC</italic> mutant alleles as indicated above.</p></sec><sec id="S33"><title>Statistical analyses</title><p id="P68">For RNA sequencing analysis, statistical significance was determined using the DESeq function in R, which uses a Wald test (two-tailed), see detailed methods. Gene set enrichment was performed as described in the methods. For other data, p values were calculated using the ‘stat_compare_means’ function of the ggpubr package (0.40.0) in R. For comparing two or more groups of non-parametric data, a two-sample Wilcoxon test or Kruskal-Wallis were used respectively.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Video 1</label><media xlink:href="EMS158981-supplement-Supplementary_Video_1.avi" mimetype="video" mime-subtype="x-msvideo" id="d5aAdEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Video 2</label><media xlink:href="EMS158981-supplement-Supplementary_Video_2.avi" mimetype="video" mime-subtype="x-msvideo" id="d5aAdEcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Supplementary Information</label><media xlink:href="EMS158981-supplement-Supplementary_Information.pdf" mimetype="application" mime-subtype="pdf" id="d5aAdEdB" position="anchor"/></supplementary-material></sec></body><back><ack id="S34"><title>Acknowledgements</title><p>The authors thank members of the Maurice laboratory for helpful discussions and suggestions. We thank Bas Ponsioen for help with time-lapse image analysis. This work is part of the Oncode Institute, which is partly financed by the Dutch Cancer Society. This work was supported by the Netherlands Organization for Scientific Research NWO VICI Grant 91815604 (to M.M.M) and ZonMW TOP Grant 91218050 (to M.M.M., O.K. and H.J.G.S.), the IMAGINE! Gravitation grant 024.005.009 (to M.M.M. and H.J.G.S.), and Dutch Cancer Society Young Investigator Grant 11491/2018-1 (to S.J.E.S.).</p></ack><sec id="S35" sec-type="data-availability"><title>Data availability</title><p id="P69">The scRNA-seq and bulk RNA-seq data generated in this study are available from Gene Expression Omnibus (GEO) under the accession codes GSE213079 (scRNAseq), GSE213077 (bulk RNAseq various organoid lines), GSE212959 (bulk RNAseq RNF43-corrected and non-corrected HUB040 organoids), GSE220128 (bulk RNAseq TINC reporter cells), GSE213068 (bulk RNAseq APC mutant and wildtype HUB040 organoids) and GSE213072 (bulk RNAseq HUB040 organoids treated with LGK-974).</p><p id="P70">Published scRNA-seq data referenced in the study is available from Synapse under the accession code syn26844071. Published microarray and bulk RNA-seq are available from Gene Expression Omnibus (GEO) under the accession codes GSE41258 and GSE50760, respectively.</p></sec><fn-group><fn id="FN1" fn-type="con"><p id="P71"><bold>Author Contributions</bold></p><p id="P72">J.M.B., L.E.B., E.K., H.J.G.S., O.K. and M.M.M. conceptualized the project. J.M.B., O.K. and M.M.M. designed and interpreted experimental results. J.M.B. generated CRISPR lines, performed all <italic>in vitro</italic> organoids experiments and analysed single-cell and bulk RNAseq data, E.K. performed <italic>in vivo</italic> transplantation experiments and immunohistochemistry, L.E.B. prepared the PDO panel for RNAseq (<xref ref-type="fig" rid="F1">Figure 1C</xref>), Y.H. and S.T., provided and analysed single-cell RNAseq patient data, J.S. designed and cloned the TINC-reporter construct and advised on single cell RNAseq analysis. I.J. performed FACS sorting and helped with image processing and analysis. N.F. designed the CRISPR strategy for <italic>RNF43</italic> correction and performed C59 experiments. D.M.G. and R.V.B. analysed and interpreted genomics data. S.J.E.S. performed time-lapse imaging and advised on hybrid co-culture experiments. J.M.B. and M.M.M. wrote the manuscript, which was reviewed by all authors.</p></fn><fn id="FN2" fn-type="conflict"><p id="P73"><bold>Declaration of interests</bold></p><p id="P74">Madelon Maurice is cofounder and shareholder of Laigo Bio B.V. The other authors declare no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spit</surname><given-names>M</given-names></name><name><surname>Koo</surname><given-names>BK</given-names></name><name><surname>Maurice</surname><given-names>MM</given-names></name></person-group><article-title>Tales from the crypt: Intestinal niche signals in tissue renewal, plasticity and cancer</article-title><source>Open Biol</source><year>2018</year><volume>8</volume><pub-id pub-id-type="pmcid">PMC6170508</pub-id><pub-id pub-id-type="pmid">30209039</pub-id><pub-id pub-id-type="doi">10.1098/rsob.180120</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Vries</surname><given-names>RG</given-names></name><name><surname>Snippert</surname><given-names>HJ</given-names></name><name><surname>Van De Wetering</surname><given-names>M</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Stange</surname><given-names>DE</given-names></name><name><surname>Van Es</surname><given-names>JH</given-names></name><name><surname>Abo</surname><given-names>A</given-names></name><name><surname>Kujala</surname><given-names>P</given-names></name><name><surname>Peters</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Single Lgr5 stem cells build crypt – villus structures in vitro without a mesenchymal niche</article-title><source>Nature</source><year>2009</year><volume>459</volume><fpage>262</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">19329995</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumagalli</surname><given-names>A</given-names></name><name><surname>Drost</surname><given-names>J</given-names></name><name><surname>Suijkerbuijk</surname><given-names>SJEE</given-names></name><name><surname>Van Boxtel</surname><given-names>R</given-names></name><name><surname>De Ligt</surname><given-names>J</given-names></name><name><surname>Offerhaus</surname><given-names>GJ</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>Beerling</surname><given-names>E</given-names></name><name><surname>Tan</surname><given-names>EH</given-names></name><name><surname>Sansom</surname><given-names>OJ</given-names></name><etal/></person-group><article-title>Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids</article-title><source>Proc Natl Acad Sci U S A</source><year>2017</year><volume>114</volume><fpage>E2357</fpage><lpage>E2364</lpage><pub-id pub-id-type="pmcid">PMC5373343</pub-id><pub-id pub-id-type="pmid">28270604</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1701219114</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Shimokawa</surname><given-names>M</given-names></name><name><surname>Date</surname><given-names>S</given-names></name><name><surname>Takano</surname><given-names>A</given-names></name><name><surname>Matano</surname><given-names>M</given-names></name><name><surname>Nanki</surname><given-names>K</given-names></name><name><surname>Ohta</surname><given-names>Y</given-names></name><name><surname>Toshimitsu</surname><given-names>K</given-names></name><name><surname>Nakazato</surname><given-names>Y</given-names></name><name><surname>Kawasaki</surname><given-names>K</given-names></name><etal/></person-group><article-title>A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis</article-title><source>Cell Stem Cell</source><year>2016</year><volume>18</volume><fpage>827</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">27212702</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fearon</surname><given-names>EF</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name></person-group><source>A Genetic Model for Colorectal Tumorigenesis</source><year>1989</year><volume>61</volume><fpage>759</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">2188735</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joanito</surname><given-names>I</given-names></name><name><surname>Wirapati</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Nawaz</surname><given-names>Z</given-names></name><name><surname>Yeo</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>F</given-names></name><name><surname>Eng</surname><given-names>CLP</given-names></name><name><surname>Macalinao</surname><given-names>DC</given-names></name><name><surname>Kahraman</surname><given-names>M</given-names></name><name><surname>Srinivasan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer</article-title><source>Nat Genet</source><year>2022</year><volume>54</volume><fpage>963</fpage><lpage>975</lpage><pub-id pub-id-type="pmcid">PMC9279158</pub-id><pub-id pub-id-type="pmid">35773407</pub-id><pub-id pub-id-type="doi">10.1038/s41588-022-01100-4</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>LH</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>DC</given-names></name></person-group><article-title>Pathways of Colorectal Carcinogenesis</article-title><source>Gastroenterology</source><year>2020</year><volume>158</volume><fpage>291</fpage><lpage>302</lpage><pub-id pub-id-type="pmcid">PMC6981255</pub-id><pub-id pub-id-type="pmid">31622622</pub-id><pub-id pub-id-type="doi">10.1053/j.gastro.2019.08.059</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugter</surname><given-names>JM</given-names></name><name><surname>Fenderico</surname><given-names>N</given-names></name><name><surname>Maurice</surname><given-names>MM</given-names></name></person-group><article-title>Mutations and mechanisms of WNT pathway tumour suppressors in cancer</article-title><source>Nat Rev Cancer</source><year>2021</year><volume>21</volume><fpage>5</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">33097916</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Scurrah</surname><given-names>CR</given-names></name><name><surname>McKinley</surname><given-names>ET</given-names></name><name><surname>Simmons</surname><given-names>AJ</given-names></name><name><surname>Ramirez-Solano</surname><given-names>MA</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Markham</surname><given-names>NO</given-names></name><name><surname>Heiser</surname><given-names>CN</given-names></name><name><surname>Vega</surname><given-names>PN</given-names></name><name><surname>Rolong</surname><given-names>A</given-names></name><etal/></person-group><article-title>Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>6262</fpage><lpage>6280</lpage><elocation-id>e26</elocation-id><pub-id pub-id-type="pmcid">PMC8941949</pub-id><pub-id pub-id-type="pmid">34910928</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.11.031</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>HHNN</given-names></name><name><surname>Lai</surname><given-names>JCWW</given-names></name><name><surname>Ho</surname><given-names>SL</given-names></name><name><surname>Leung</surname><given-names>WK</given-names></name><name><surname>Law</surname><given-names>WL</given-names></name><name><surname>Lee</surname><given-names>JFYY</given-names></name><name><surname>Chan</surname><given-names>ASYAKWYAKW</given-names></name><name><surname>Tsui</surname><given-names>WY</given-names></name><name><surname>Chan</surname><given-names>ASYAKWYAKW</given-names></name><name><surname>Lee</surname><given-names>BCHH</given-names></name><etal/></person-group><article-title>RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation</article-title><source>Gut</source><year>2017</year><volume>66</volume><fpage>1645</fpage><lpage>1656</lpage><pub-id pub-id-type="pmid">27329244</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>AJ</given-names></name><name><surname>Serra</surname><given-names>S</given-names></name><name><surname>Chetty</surname><given-names>R</given-names></name></person-group><article-title>Traditional serrated adenoma: an overview of pathology and emphasis on molecular pathogenesis</article-title><source>BMJ Open Gastroenterol</source><year>2019</year><volume>6</volume><elocation-id>e000317</elocation-id><pub-id pub-id-type="pmcid">PMC6673762</pub-id><pub-id pub-id-type="pmid">31413858</pub-id><pub-id pub-id-type="doi">10.1136/bmjgast-2019-000317</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>R</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Sekine</surname><given-names>S</given-names></name></person-group><article-title>Acquisition of WNT pathway gene alterations coincides with the transition from precursor polyps to traditional serrated adenomas</article-title><source>Am J Surg Pathol</source><year>2019</year><volume>43</volume><fpage>132</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">30179900</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van De Wetering</surname><given-names>M</given-names></name><name><surname>Francies</surname><given-names>HE</given-names></name><name><surname>Francis</surname><given-names>JM</given-names></name><name><surname>Bounova</surname><given-names>G</given-names></name><name><surname>Iorio</surname><given-names>F</given-names></name><name><surname>Pronk</surname><given-names>A</given-names></name><name><surname>Van Houdt</surname><given-names>W</given-names></name><name><surname>Van Gorp</surname><given-names>J</given-names></name><name><surname>Taylor-Weiner</surname><given-names>A</given-names></name><name><surname>Kester</surname><given-names>L</given-names></name><etal/></person-group><article-title>Prospective derivation of a living organoid biobank of colorectal cancer patients</article-title><source>Cell</source><year>2015</year><volume>161</volume><fpage>933</fpage><lpage>945</lpage><pub-id pub-id-type="pmcid">PMC6428276</pub-id><pub-id pub-id-type="pmid">25957691</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2015.03.053</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elez</surname><given-names>E</given-names></name><name><surname>Ros</surname><given-names>J</given-names></name><name><surname>Fernández</surname><given-names>J</given-names></name><name><surname>Villacampa</surname><given-names>G</given-names></name><name><surname>Moreno-cárdenas</surname><given-names>AB</given-names></name><name><surname>Arenillas</surname><given-names>C</given-names></name><name><surname>Bernatowicz</surname><given-names>K</given-names></name><name><surname>Comas</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Kodack</surname><given-names>DP</given-names></name><etal/></person-group><article-title>RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer</article-title><source>Nat Med</source><year>2022</year><volume>28</volume><pub-id pub-id-type="pmcid">PMC9556333</pub-id><pub-id pub-id-type="pmid">36097219</pub-id><pub-id pub-id-type="doi">10.1038/s41591-022-01976-z</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleeman</surname><given-names>SO</given-names></name><name><surname>Koelzer</surname><given-names>VH</given-names></name><name><surname>Jones</surname><given-names>HJS</given-names></name><name><surname>Vazquez</surname><given-names>EG</given-names></name><name><surname>Davis</surname><given-names>H</given-names></name><name><surname>East</surname><given-names>JE</given-names></name><name><surname>Arnold</surname><given-names>R</given-names></name><name><surname>Koppens</surname><given-names>MAJ</given-names></name><name><surname>Blake</surname><given-names>A</given-names></name><name><surname>Domingo</surname><given-names>E</given-names></name><etal/></person-group><article-title>Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification</article-title><source>Gut</source><year>2020</year><volume>69</volume><fpage>1092</fpage><lpage>1103</lpage><pub-id pub-id-type="pmcid">PMC7212029</pub-id><pub-id pub-id-type="pmid">31563876</pub-id><pub-id pub-id-type="doi">10.1136/gutjnl-2019-319126</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ubink</surname><given-names>I</given-names></name><name><surname>Bolhaqueiro</surname><given-names>ACF</given-names></name><name><surname>Elias</surname><given-names>SG</given-names></name><name><surname>Raats</surname><given-names>DAE</given-names></name><name><surname>Constantinides</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>NA</given-names></name><name><surname>Wassenaar</surname><given-names>ECE</given-names></name><name><surname>de Hingh</surname><given-names>IHJT</given-names></name><name><surname>Rovers</surname><given-names>KP</given-names></name><name><surname>van Grevenstein</surname><given-names>WMU</given-names></name><etal/></person-group><article-title>Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy</article-title><source>Br J Surg</source><year>2019</year><volume>106</volume><fpage>1404</fpage><lpage>1414</lpage><pub-id pub-id-type="pmcid">PMC6771632</pub-id><pub-id pub-id-type="pmid">31197820</pub-id><pub-id pub-id-type="doi">10.1002/bjs.11206</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumagalli</surname><given-names>A</given-names></name><name><surname>Suijkerbuijk</surname><given-names>SJE</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>Beerling</surname><given-names>E</given-names></name><name><surname>Oost</surname><given-names>KC</given-names></name><name><surname>Snippert</surname><given-names>HJ</given-names></name><name><surname>Van Rheenen</surname><given-names>J</given-names></name><name><surname>Drost</surname><given-names>J</given-names></name></person-group><article-title>A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression</article-title><source>Nat Protoc</source><year>2018</year><volume>13</volume><fpage>235</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">29300390</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Sachs</surname><given-names>N</given-names></name><name><surname>Wiebrands</surname><given-names>K</given-names></name><name><surname>Ellenbroek</surname><given-names>SIJ</given-names></name><name><surname>Fumagalli</surname><given-names>A</given-names></name><name><surname>Lyubimova</surname><given-names>A</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>Den Van Born</surname><given-names>M</given-names></name><name><surname>Van Es</surname><given-names>JH</given-names></name><name><surname>Karthaus</surname><given-names>WR</given-names></name><etal/></person-group><article-title>Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><fpage>E5399</fpage><lpage>E5407</lpage><pub-id pub-id-type="pmcid">PMC5027439</pub-id><pub-id pub-id-type="pmid">27573849</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1607327113</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>Z</given-names></name><name><surname>Fu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>YG</given-names></name><name><surname>Chen</surname><given-names>YG</given-names></name></person-group><article-title>Single-cell transcriptome analysis reveals differential nutrient absorption functions in human intestine</article-title><source>J Exp Med</source><year>2020</year><volume>217</volume><pub-id pub-id-type="pmcid">PMC7041720</pub-id><pub-id pub-id-type="pmid">31753849</pub-id><pub-id pub-id-type="doi">10.1084/jem.20191130</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krotenberg Garcia</surname><given-names>A</given-names></name><name><surname>van Rheenen</surname><given-names>J</given-names></name><name><surname>Suijkerbuijk</surname><given-names>SJE</given-names></name></person-group><article-title>Generation of mixed murine organoids to model cellular interactions</article-title><source>STAR Protoc</source><year>2021</year><volume>2</volume><elocation-id>100997</elocation-id><pub-id pub-id-type="pmcid">PMC8666359</pub-id><pub-id pub-id-type="pmid">34917977</pub-id><pub-id pub-id-type="doi">10.1016/j.xpro.2021.100997</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>BK</given-names></name><name><surname>Spit</surname><given-names>M</given-names></name><name><surname>Jordens</surname><given-names>I</given-names></name><name><surname>Low</surname><given-names>TY</given-names></name><name><surname>Stange</surname><given-names>DE</given-names></name><name><surname>Van De Wetering</surname><given-names>M</given-names></name><name><surname>Van Es</surname><given-names>JH</given-names></name><name><surname>Mohammed</surname><given-names>S</given-names></name><name><surname>Heck</surname><given-names>AJR</given-names></name><name><surname>Maurice</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors</article-title><source>Nature</source><year>2012</year><volume>488</volume><fpage>665</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">22895187</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>Snippert</surname><given-names>HJ</given-names></name><name><surname>Stange</surname><given-names>DE</given-names></name><name><surname>Vries</surname><given-names>RG</given-names></name><name><surname>van den Born</surname><given-names>M</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts</article-title><source>Nature</source><year>2011</year><volume>469</volume><fpage>415</fpage><lpage>418</lpage><pub-id pub-id-type="pmcid">PMC3547360</pub-id><pub-id pub-id-type="pmid">21113151</pub-id><pub-id pub-id-type="doi">10.1038/nature09637</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oost</surname><given-names>KC</given-names></name><name><surname>van Voorthuijsen</surname><given-names>L</given-names></name><name><surname>Fumagalli</surname><given-names>A</given-names></name><name><surname>Lindeboom</surname><given-names>RGH</given-names></name><name><surname>Sprangers</surname><given-names>J</given-names></name><name><surname>Omerzu</surname><given-names>M</given-names></name><name><surname>Rodriguez-Colman</surname><given-names>MJ</given-names></name><name><surname>Heinz</surname><given-names>MC</given-names></name><name><surname>Verlaan-Klink</surname><given-names>I</given-names></name><name><surname>Maurice</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Specific Labeling of Stem Cell Activity in Human Colorectal Organoids Using an ASCL2-Responsive Minigene</article-title><source>Cell Rep</source><year>2018</year><volume>22</volume><fpage>1600</fpage><lpage>1614</lpage><pub-id pub-id-type="pmcid">PMC5847189</pub-id><pub-id pub-id-type="pmid">29425513</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2018.01.033</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Colman</surname><given-names>MJ</given-names></name><name><surname>Schewe</surname><given-names>M</given-names></name><name><surname>Meerlo</surname><given-names>M</given-names></name><name><surname>Stigter</surname><given-names>E</given-names></name><name><surname>Gerrits</surname><given-names>J</given-names></name><name><surname>Pras-Raves</surname><given-names>M</given-names></name><name><surname>Sacchetti</surname><given-names>A</given-names></name><name><surname>Hornsveld</surname><given-names>M</given-names></name><name><surname>Oost</surname><given-names>KC</given-names></name><name><surname>Snippert</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Interplay between metabolic identities in the intestinal crypt supports stem cell function</article-title><source>Nature</source><year>2017</year><volume>543</volume><fpage>424</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">28273069</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname><given-names>LE</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Colgan</surname><given-names>SP</given-names></name></person-group><article-title>Oxygen metabolism and barrier regulation in the intestinal mucosa</article-title><source>J Clin Invest</source><year>2016</year><volume>126</volume><fpage>3680</fpage><lpage>3688</lpage><pub-id pub-id-type="pmcid">PMC5096807</pub-id><pub-id pub-id-type="pmid">27500494</pub-id><pub-id pub-id-type="doi">10.1172/JCI84429</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Huo</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name></person-group><article-title>Unfolded protein response in colorectal cancer</article-title><source>Cell Biosci</source><year>2021</year><volume>11</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC7844992</pub-id><pub-id pub-id-type="pmid">33514437</pub-id><pub-id pub-id-type="doi">10.1186/s13578-021-00538-z</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname><given-names>LL</given-names></name><name><surname>Davis</surname><given-names>AK</given-names></name><name><surname>Grogg</surname><given-names>MW</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name></person-group><article-title>MTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice</article-title><source>FASEB J</source><year>2016</year><volume>30</volume><fpage>1263</fpage><lpage>1275</lpage><pub-id pub-id-type="pmcid">PMC4750410</pub-id><pub-id pub-id-type="pmid">26631481</pub-id><pub-id pub-id-type="doi">10.1096/fj.15-278606</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>DeMartino</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Staliarova</surname><given-names>N</given-names></name><name><surname>Dayton</surname><given-names>T</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>van de Wetering</surname><given-names>WJ</given-names></name><name><surname>Bodewes</surname><given-names>E</given-names></name><name><surname>van Zon</surname><given-names>J</given-names></name><etal/></person-group><article-title>Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation</article-title><source>Cell Stem Cell</source><year>2022</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC9746670</pub-id><pub-id pub-id-type="pmid">36459971</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2022.11.001</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cañellas-Socias</surname><given-names>A</given-names></name><name><surname>Cortina</surname><given-names>C</given-names></name><name><surname>Hernando-Momblona</surname><given-names>X</given-names></name><name><surname>Palomo-Ponce</surname><given-names>S</given-names></name><name><surname>Mulholland</surname><given-names>EJ</given-names></name><name><surname>Turon</surname><given-names>G</given-names></name><name><surname>Mateo</surname><given-names>L</given-names></name><name><surname>Conti</surname><given-names>S</given-names></name><name><surname>Roman</surname><given-names>O</given-names></name><name><surname>Sevillano</surname><given-names>M</given-names></name><etal/></person-group><article-title>Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells</article-title><source>Nature</source><year>2022</year><pub-id pub-id-type="pmid">36352230</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasquez</surname><given-names>EG</given-names></name><name><surname>Nasreddin</surname><given-names>N</given-names></name><name><surname>Valbuena</surname><given-names>GN</given-names></name><name><surname>Mulholland</surname><given-names>EJ</given-names></name><name><surname>Belnoue-Davis</surname><given-names>HL</given-names></name><name><surname>Eggington</surname><given-names>HR</given-names></name><name><surname>Schenck</surname><given-names>RO</given-names></name><name><surname>Wouters</surname><given-names>VM</given-names></name><name><surname>Wirapati</surname><given-names>P</given-names></name><name><surname>Gilroy</surname><given-names>K</given-names></name><etal/></person-group><article-title>Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia</article-title><source>Cell Stem Cell</source><year>2022</year><volume>29</volume><fpage>1213</fpage><lpage>1228</lpage><elocation-id>e8</elocation-id><pub-id pub-id-type="pmcid">PMC9592560</pub-id><pub-id pub-id-type="pmid">35931031</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2022.07.008</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drost</surname><given-names>J</given-names></name><name><surname>Van Jaarsveld</surname><given-names>RH</given-names></name><name><surname>Ponsioen</surname><given-names>B</given-names></name><name><surname>Zimberlin</surname><given-names>C</given-names></name><name><surname>Van Boxtel</surname><given-names>R</given-names></name><name><surname>Buijs</surname><given-names>A</given-names></name><name><surname>Sachs</surname><given-names>N</given-names></name><name><surname>Overmeer</surname><given-names>RM</given-names></name><name><surname>Offerhaus</surname><given-names>GJ</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sequential cancer mutations in cultured human intestinal stem cells</article-title><source>Nature</source><year>2015</year><volume>521</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">25924068</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannakis</surname><given-names>M</given-names></name><name><surname>Hodis</surname><given-names>E</given-names></name><name><surname>Jasmine Mu</surname><given-names>X</given-names></name><name><surname>Yamauchi</surname><given-names>M</given-names></name><name><surname>Rosenbluh</surname><given-names>J</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Saksena</surname><given-names>G</given-names></name><name><surname>Lawrence</surname><given-names>MS</given-names></name><name><surname>Qian</surname><given-names>ZR</given-names></name><name><surname>Nishihara</surname><given-names>R</given-names></name><etal/></person-group><article-title>RNF43 is frequently mutated in colorectal and endometrial cancers</article-title><source>Nat Genet</source><year>2014</year><volume>46</volume><fpage>1264</fpage><lpage>1266</lpage><pub-id pub-id-type="pmcid">PMC4283570</pub-id><pub-id pub-id-type="pmid">25344691</pub-id><pub-id pub-id-type="doi">10.1038/ng.3127</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michels</surname><given-names>BE</given-names></name><name><surname>Mosa</surname><given-names>MH</given-names></name><name><surname>Grebbin</surname><given-names>BM</given-names></name><name><surname>Yepes</surname><given-names>D</given-names></name><name><surname>Darvishi</surname><given-names>T</given-names></name><name><surname>Hausmann</surname><given-names>J</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Zeuzem</surname><given-names>S</given-names></name><name><surname>Kvasnicka</surname><given-names>HM</given-names></name><name><surname>Oellerich</surname><given-names>T</given-names></name><etal/></person-group><article-title>Human colon organoids reveal distinct physiologic and oncogenic Wnt responses</article-title><source>J Exp Med</source><year>2019</year><volume>216</volume><fpage>704</fpage><lpage>720</lpage><pub-id pub-id-type="pmcid">PMC6400532</pub-id><pub-id pub-id-type="pmid">30792186</pub-id><pub-id pub-id-type="doi">10.1084/jem.20180823</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlitz</surname><given-names>F</given-names></name><name><surname>Bischoff</surname><given-names>P</given-names></name><name><surname>Peidli</surname><given-names>S</given-names></name><name><surname>Sieber</surname><given-names>A</given-names></name><name><surname>Trinks</surname><given-names>A</given-names></name><name><surname>Lüthen</surname><given-names>M</given-names></name><name><surname>Obermayer</surname><given-names>B</given-names></name><name><surname>Blanc</surname><given-names>E</given-names></name><name><surname>Ruchiy</surname><given-names>Y</given-names></name><name><surname>Sell</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer</article-title><source>EMBO Mol Med</source><year>2021</year><volume>13</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmcid">PMC8495451</pub-id><pub-id pub-id-type="pmid">34409732</pub-id><pub-id pub-id-type="doi">10.15252/emmm.202114123</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>SA</given-names></name><name><surname>Policastro</surname><given-names>RA</given-names></name><name><surname>Sriramkumar</surname><given-names>S</given-names></name><name><surname>Lai</surname><given-names>T</given-names></name><name><surname>Huntington</surname><given-names>TD</given-names></name><name><surname>Ladaika</surname><given-names>CA</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Hao</surname><given-names>C</given-names></name><name><surname>Zentner</surname><given-names>GE</given-names></name><name><surname>O’Hagan</surname><given-names>HM</given-names></name></person-group><article-title>LSD1 and aberrant DNA methylation mediate persistence of enteroendocrine progenitors that support BRAF-mutant colorectal cancer</article-title><source>Cancer Res</source><year>2021</year><volume>81</volume><fpage>3791</fpage><lpage>3805</lpage><pub-id pub-id-type="pmcid">PMC8513805</pub-id><pub-id pub-id-type="pmid">34035083</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-20-3562</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimokawa</surname><given-names>M</given-names></name><name><surname>Ohta</surname><given-names>Y</given-names></name><name><surname>Nishikori</surname><given-names>S</given-names></name><name><surname>Matano</surname><given-names>M</given-names></name><name><surname>Takano</surname><given-names>A</given-names></name><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Date</surname><given-names>S</given-names></name><name><surname>Sugimoto</surname><given-names>S</given-names></name><name><surname>Kanai</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name></person-group><article-title>Visualization and targeting of LGR5+ human colon cancer stem cells</article-title><source>Nature</source><year>2017</year><volume>545</volume><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">28355176</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morral</surname><given-names>C</given-names></name><name><surname>Stanisavljevic</surname><given-names>J</given-names></name><name><surname>Hernando-Momblona</surname><given-names>X</given-names></name><name><surname>Mereu</surname><given-names>E</given-names></name><name><surname>Álvarez-Varela</surname><given-names>A</given-names></name><name><surname>Cortina</surname><given-names>C</given-names></name><name><surname>Stork</surname><given-names>D</given-names></name><name><surname>Slebe</surname><given-names>F</given-names></name><name><surname>Turon</surname><given-names>G</given-names></name><name><surname>Whissell</surname><given-names>G</given-names></name><etal/></person-group><article-title>Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal Cancer</article-title><source>Cell Stem Cell</source><year>2020</year><volume>26</volume><fpage>845</fpage><lpage>861</lpage><elocation-id>e12</elocation-id><pub-id pub-id-type="pmcid">PMC9006079</pub-id><pub-id pub-id-type="pmid">32396863</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2020.04.012</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacchetti</surname><given-names>A</given-names></name><name><surname>Teeuwssen</surname><given-names>M</given-names></name><name><surname>Verhagen</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Stabile</surname><given-names>R</given-names></name><name><surname>van der Steen</surname><given-names>B</given-names></name><name><surname>Watson</surname><given-names>MM</given-names></name><name><surname>Gusinac</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>WK</given-names></name><etal/></person-group><article-title>Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer</article-title><source>Elife</source><year>2021</year><volume>10</volume><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="pmcid">PMC8192123</pub-id><pub-id pub-id-type="pmid">34036938</pub-id><pub-id pub-id-type="doi">10.7554/eLife.61461</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Heijden</surname><given-names>M</given-names></name><name><surname>Miedema</surname><given-names>DM</given-names></name><name><surname>Waclaw</surname><given-names>B</given-names></name><name><surname>Veenstra</surname><given-names>VL</given-names></name><name><surname>Lecca</surname><given-names>MC</given-names></name><name><surname>Nijman</surname><given-names>LE</given-names></name><name><surname>Van Dijk</surname><given-names>E</given-names></name><name><surname>Van Neerven</surname><given-names>SM</given-names></name><name><surname>Lodestijn</surname><given-names>SC</given-names></name><name><surname>Lenos</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts</article-title><source>Proc Natl Acad Sci U S A</source><year>2019</year><volume>116</volume><fpage>6140</fpage><lpage>6145</lpage><pub-id pub-id-type="pmcid">PMC6442578</pub-id><pub-id pub-id-type="pmid">30850544</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1813417116</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumagalli</surname><given-names>A</given-names></name><name><surname>Oost</surname><given-names>KC</given-names></name><name><surname>Kester</surname><given-names>L</given-names></name><name><surname>Morgner</surname><given-names>J</given-names></name><name><surname>Bornes</surname><given-names>L</given-names></name><name><surname>Bruens</surname><given-names>L</given-names></name><name><surname>Spaargaren</surname><given-names>L</given-names></name><name><surname>Azkanaz</surname><given-names>M</given-names></name><name><surname>Schelfhorst</surname><given-names>T</given-names></name><name><surname>Beerling</surname><given-names>E</given-names></name><etal/></person-group><article-title>Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer</article-title><source>Cell Stem Cell</source><year>2020</year><volume>26</volume><fpage>569</fpage><lpage>578</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmcid">PMC7118369</pub-id><pub-id pub-id-type="pmid">32169167</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2020.02.008</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname><given-names>MC</given-names></name><name><surname>Peters</surname><given-names>NA</given-names></name><name><surname>Oost</surname><given-names>KC</given-names></name><name><surname>Lindeboom</surname><given-names>RGH</given-names></name><name><surname>van Voorthuijsen</surname><given-names>L</given-names></name><name><surname>Fumagalli</surname><given-names>A</given-names></name><name><surname>van der Net</surname><given-names>MC</given-names></name><name><surname>de Medeiros</surname><given-names>G</given-names></name><name><surname>Hageman</surname><given-names>JH</given-names></name><name><surname>Verlaan-Klink</surname><given-names>I</given-names></name><etal/></person-group><article-title>Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage</article-title><source>Cancer Res</source><year>2022</year><volume>82</volume><fpage>1953</fpage><lpage>1968</lpage><pub-id pub-id-type="pmcid">PMC9381095</pub-id><pub-id pub-id-type="pmid">35570706</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-21-0933</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Ford-Roshon</surname><given-names>D</given-names></name><name><surname>Russo</surname><given-names>M</given-names></name><name><surname>O’Brien</surname><given-names>C</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Gurjao</surname><given-names>C</given-names></name><name><surname>Grandclaudon</surname><given-names>M</given-names></name><name><surname>Raghavan</surname><given-names>S</given-names></name><name><surname>Corsello</surname><given-names>SM</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name><etal/></person-group><article-title>RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmcid">PMC9177965</pub-id><pub-id pub-id-type="pmid">35676246</pub-id><pub-id pub-id-type="doi">10.1038/s41467-022-30794-7</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoxhaj</surname><given-names>G</given-names></name><name><surname>Manning</surname><given-names>BD</given-names></name></person-group><article-title>The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism</article-title><source>Nat Rev Cancer</source><year>2020</year><volume>20</volume><fpage>74</fpage><lpage>88</lpage><pub-id pub-id-type="pmcid">PMC7314312</pub-id><pub-id pub-id-type="pmid">31686003</pub-id><pub-id pub-id-type="doi">10.1038/s41568-019-0216-7</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Rychahou</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Weiss</surname><given-names>HL</given-names></name><name><surname>Evers</surname><given-names>BM</given-names></name></person-group><article-title>TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmcid">PMC4669793</pub-id><pub-id pub-id-type="pmid">25654764</pub-id><pub-id pub-id-type="doi">10.1038/cddis.2014.588</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>A</given-names></name><name><surname>Safronova</surname><given-names>A</given-names></name><name><surname>Burger</surname><given-names>E</given-names></name><name><surname>López-Yglesias</surname><given-names>A</given-names></name><name><surname>Giri</surname><given-names>S</given-names></name><name><surname>Camanzo</surname><given-names>ET</given-names></name><name><surname>Martin</surname><given-names>AT</given-names></name><name><surname>Grivennikov</surname><given-names>S</given-names></name><name><surname>Yarovinsky</surname><given-names>F</given-names></name></person-group><article-title>IFN-γ mediates Paneth cell death via suppression of mTOR</article-title><source>Elife</source><year>2021</year><volume>10</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmcid">PMC8570691</pub-id><pub-id pub-id-type="pmid">34633285</pub-id><pub-id pub-id-type="doi">10.7554/eLife.60478</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugen</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>G</given-names></name><name><surname>Glynne-Jones</surname><given-names>R</given-names></name><name><surname>De Wilt</surname><given-names>JHW</given-names></name><name><surname>Nagtegaal</surname><given-names>ID</given-names></name></person-group><article-title>Advances in the care of patients with mucinous colorectal cancer</article-title><source>Nat Rev Clin Oncol</source><year>2016</year><volume>13</volume><fpage>361</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">26323388</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kufe</surname><given-names>DW</given-names></name></person-group><article-title>Mucins in cancer: function, prognosis and therapy</article-title><source>Nat Rev Cancer</source><year>2009</year><volume>9</volume><fpage>874</fpage><lpage>885</lpage><pub-id pub-id-type="pmcid">PMC2951677</pub-id><pub-id pub-id-type="pmid">19935676</pub-id><pub-id pub-id-type="doi">10.1038/nrc2761</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryland</surname><given-names>GL</given-names></name><name><surname>Hunter</surname><given-names>SM</given-names></name><name><surname>Doyle</surname><given-names>MA</given-names></name><name><surname>Rowley</surname><given-names>SM</given-names></name><name><surname>Christie</surname><given-names>M</given-names></name><name><surname>Allan</surname><given-names>PE</given-names></name><name><surname>Bowtell</surname><given-names>DD</given-names></name><name><surname>Gorringe</surname><given-names>KL</given-names></name><name><surname>Campbell</surname><given-names>IG</given-names></name></person-group><article-title>RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary</article-title><source>J Pathol</source><year>2013</year><volume>229</volume><fpage>469</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">23096461</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Choi</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name></person-group><article-title>KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis</article-title><source>Springerplus</source><year>2016</year><volume>5</volume><pub-id pub-id-type="pmcid">PMC4960083</pub-id><pub-id pub-id-type="pmid">27512631</pub-id><pub-id pub-id-type="doi">10.1186/s40064-016-2847-4</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>H</given-names></name><name><surname>Kuboki</surname><given-names>Y</given-names></name><name><surname>Hatori</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Sugiyama</surname><given-names>M</given-names></name><name><surname>Shibata</surname><given-names>N</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Shiratori</surname><given-names>K</given-names></name><name><surname>Furukawa</surname><given-names>T</given-names></name></person-group><article-title>Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas</article-title><source>Mod Pathol</source><year>2015</year><volume>28</volume><fpage>261</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">25081753</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheffer</surname><given-names>M</given-names></name><name><surname>Bacolod</surname><given-names>MD</given-names></name><name><surname>Zuk</surname><given-names>O</given-names></name><name><surname>Giardina</surname><given-names>SF</given-names></name><name><surname>Pincas</surname><given-names>H</given-names></name><name><surname>Barany</surname><given-names>F</given-names></name><name><surname>Paty</surname><given-names>PB</given-names></name><name><surname>Gerald</surname><given-names>WL</given-names></name><name><surname>Notterman</surname><given-names>DA</given-names></name><name><surname>Domany</surname><given-names>E</given-names></name></person-group><article-title>Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><fpage>7131</fpage><lpage>7136</lpage><pub-id pub-id-type="pmcid">PMC2678450</pub-id><pub-id pub-id-type="pmid">19359472</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0902232106</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Flier</surname><given-names>LG</given-names></name><name><surname>Sabates-Bellver</surname><given-names>J</given-names></name><name><surname>Oving</surname><given-names>I</given-names></name><name><surname>Haegebarth</surname><given-names>A</given-names></name><name><surname>De Palo</surname><given-names>M</given-names></name><name><surname>Anti</surname><given-names>M</given-names></name><name><surname>Van Gijn</surname><given-names>ME</given-names></name><name><surname>Suijkerbuijk</surname><given-names>S</given-names></name><name><surname>Van de Wetering</surname><given-names>M</given-names></name><name><surname>Marra</surname><given-names>G</given-names></name><etal/></person-group><article-title>The Intestinal Wnt/TCF Signature</article-title><source>Gastroenterology</source><year>2007</year><volume>132</volume><fpage>628</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">17320548</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>Ha</surname><given-names>A</given-names></name><name><surname>de Lau</surname><given-names>W</given-names></name><name><surname>Yuki</surname><given-names>K</given-names></name><name><surname>Santos</surname><given-names>AJM</given-names></name><name><surname>You</surname><given-names>C</given-names></name><name><surname>Geurts</surname><given-names>MH</given-names></name><name><surname>Puschhof</surname><given-names>J</given-names></name><name><surname>Pleguezuelos-Manzano</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>WC</given-names></name><etal/></person-group><article-title>Next-Generation Surrogate Wnts Support Organoid Growth and Deconvolute Frizzled Pleiotropy In Vivo</article-title><source>Cell Stem Cell</source><year>2020</year><volume>27</volume><fpage>840</fpage><lpage>851</lpage><elocation-id>e6</elocation-id><pub-id pub-id-type="pmcid">PMC7655723</pub-id><pub-id pub-id-type="pmid">32818433</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2020.07.020</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bollen</surname><given-names>Y</given-names></name><name><surname>Post</surname><given-names>J</given-names></name><name><surname>Koo</surname><given-names>B-K</given-names></name><name><surname>Snippert</surname><given-names>HJG</given-names></name></person-group><article-title>How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editing</article-title><source>Nucleic Acids Res</source><year>2018</year><volume>46</volume><fpage>6435</fpage><lpage>6454</lpage><pub-id pub-id-type="pmcid">PMC6061873</pub-id><pub-id pub-id-type="pmid">29955892</pub-id><pub-id pub-id-type="doi">10.1093/nar/gky571</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>CD</given-names></name><name><surname>Ray</surname><given-names>GJ</given-names></name><name><surname>DeWitt</surname><given-names>MA</given-names></name><name><surname>Curie</surname><given-names>GL</given-names></name><name><surname>Corn</surname><given-names>JE</given-names></name></person-group><article-title>Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA</article-title><source>Nat Biotechnol</source><year>2016</year><volume>34</volume><fpage>339</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">26789497</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bollen</surname><given-names>Y</given-names></name><name><surname>Hageman</surname><given-names>JH</given-names></name><name><surname>van Leenen</surname><given-names>P</given-names></name><name><surname>Derks</surname><given-names>LLM</given-names></name><name><surname>Ponsioen</surname><given-names>B</given-names></name><name><surname>Buissant des Amorie</surname><given-names>JR</given-names></name><name><surname>Verlaan-Klink</surname><given-names>I</given-names></name><name><surname>van den Bos</surname><given-names>M</given-names></name><name><surname>Terstappen</surname><given-names>LWMM</given-names></name><name><surname>van Boxtel</surname><given-names>R</given-names></name><etal/></person-group><article-title>Efficient and error-free fluorescent gene tagging in human organoids without double-strand DNA cleavage</article-title><source>PLoS Biol</source><year>2022</year><volume>20</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC8827455</pub-id><pub-id pub-id-type="pmid">35089911</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3001527</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Matano</surname><given-names>M</given-names></name><name><surname>Nanki</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name></person-group><article-title>Efficient genetic engineering of human intestinal organoids using electroporation</article-title><source>Nat Protoc</source><year>2015</year><volume>10</volume><fpage>1474</fpage><lpage>1485</lpage><pub-id pub-id-type="pmid">26334867</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkman</surname><given-names>EK</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Amendola</surname><given-names>M</given-names></name><name><surname>Van Steensel</surname><given-names>B</given-names></name></person-group><article-title>Easy quantitative assessment of genome editing by sequence trace decomposition</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmcid">PMC4267669</pub-id><pub-id pub-id-type="pmid">25300484</pub-id><pub-id pub-id-type="doi">10.1093/nar/gku936</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkman</surname><given-names>EK</given-names></name><name><surname>Kousholt</surname><given-names>AN</given-names></name><name><surname>Harmsen</surname><given-names>T</given-names></name><name><surname>Leemans</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Jonkers</surname><given-names>J</given-names></name><name><surname>van Steensel</surname><given-names>B</given-names></name></person-group><article-title>Easy quantification of template-directed CRISPR/Cas9 editing</article-title><source>Nucleic Acids Res</source><year>2018</year><volume>46</volume><elocation-id>e58</elocation-id><pub-id pub-id-type="pmcid">PMC6007333</pub-id><pub-id pub-id-type="pmid">29538768</pub-id><pub-id pub-id-type="doi">10.1093/nar/gky164</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name></person-group><article-title>Fast and accurate long-read alignment with BurrowsWheeler transform</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>589</fpage><lpage>595</lpage><pub-id pub-id-type="pmcid">PMC2828108</pub-id><pub-id pub-id-type="pmid">20080505</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btp698</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarasov</surname><given-names>A</given-names></name><name><surname>Vilella</surname><given-names>AJ</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name><name><surname>Nijman</surname><given-names>IJ</given-names></name><name><surname>Prins</surname><given-names>P</given-names></name></person-group><article-title>Sambamba: Fast processing of NGS alignment formats</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>2032</fpage><lpage>2034</lpage><pub-id pub-id-type="pmcid">PMC4765878</pub-id><pub-id pub-id-type="pmid">25697820</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btv098</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>A</given-names></name><name><surname>Hanna</surname><given-names>M</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Sivachenko</surname><given-names>A</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Kernytsky</surname><given-names>A</given-names></name><name><surname>Garimella</surname><given-names>K</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Daly</surname><given-names>M</given-names></name><etal/></person-group><article-title>The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data</article-title><source>Genome Res</source><year>2010</year><volume>20</volume><fpage>1297</fpage><lpage>1303</lpage><pub-id pub-id-type="pmcid">PMC2928508</pub-id><pub-id pub-id-type="pmid">20644199</pub-id><pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeva</surname><given-names>V</given-names></name><name><surname>Popova</surname><given-names>T</given-names></name><name><surname>Bleakley</surname><given-names>K</given-names></name><name><surname>Chiche</surname><given-names>P</given-names></name><name><surname>Cappo</surname><given-names>J</given-names></name><name><surname>Schleiermacher</surname><given-names>G</given-names></name><name><surname>Janoueix-Lerosey</surname><given-names>I</given-names></name><name><surname>Delattre</surname><given-names>O</given-names></name><name><surname>Barillot</surname><given-names>E</given-names></name></person-group><article-title>Control-FREEC: A tool for assessing copy number and allelic content using next-generation sequencing data</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>423</fpage><lpage>425</lpage><pub-id pub-id-type="pmcid">PMC3268243</pub-id><pub-id pub-id-type="pmid">22155870</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btr670</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cingolani</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>VM</given-names></name><name><surname>Coon</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Land</surname><given-names>SJ</given-names></name><name><surname>Ruden</surname><given-names>DM</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name></person-group><article-title>Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, SnpSift</article-title><source>Front Genet</source><year>2012</year><volume>3</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC3304048</pub-id><pub-id pub-id-type="pmid">22435069</pub-id><pub-id pub-id-type="doi">10.3389/fgene.2012.00035</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cingolani</surname><given-names>P</given-names></name><name><surname>Platts</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Coon</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Land</surname><given-names>SJ</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Ruden</surname><given-names>DM</given-names></name></person-group><article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3</article-title><source>Fly (Austin)</source><year>2012</year><volume>6</volume><fpage>80</fpage><lpage>92</lpage><pub-id pub-id-type="pmcid">PMC3679285</pub-id><pub-id pub-id-type="pmid">22728672</pub-id><pub-id pub-id-type="doi">10.4161/fly.19695</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Eils</surname><given-names>R</given-names></name><name><surname>Schlesner</surname><given-names>M</given-names></name></person-group><article-title>Complex heatmaps reveal patterns and correlations in multidimensional genomic data</article-title><source>Bioinformatics</source><year>2016</year><volume>32</volume><fpage>2847</fpage><lpage>2849</lpage><pub-id pub-id-type="pmid">27207943</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shale</surname><given-names>C</given-names></name><name><surname>Cameron</surname><given-names>DL</given-names></name><name><surname>Baber</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Cowley</surname><given-names>MJ</given-names></name><name><surname>Papenfuss</surname><given-names>AT</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name><name><surname>Priestley</surname><given-names>P</given-names></name></person-group><article-title>Unscrambling cancer genomes via integrated analysis of structural variation and copy number</article-title><source>Cell Genomics</source><year>2022</year><volume>2</volume><elocation-id>100112</elocation-id><pub-id pub-id-type="pmcid">PMC9903802</pub-id><pub-id pub-id-type="pmid">36776527</pub-id><pub-id pub-id-type="doi">10.1016/j.xgen.2022.100112</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bankhead</surname><given-names>P</given-names></name><name><surname>Loughrey</surname><given-names>MB</given-names></name><name><surname>Fernández</surname><given-names>JA</given-names></name><name><surname>Dombrowski</surname><given-names>Y</given-names></name><name><surname>McArt</surname><given-names>DG</given-names></name><name><surname>Dunne</surname><given-names>PD</given-names></name><name><surname>McQuaid</surname><given-names>S</given-names></name><name><surname>Gray</surname><given-names>RT</given-names></name><name><surname>Murray</surname><given-names>LJ</given-names></name><name><surname>Coleman</surname><given-names>HG</given-names></name><etal/></person-group><article-title>QuPath: Open source software for digital pathology image analysis</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC5715110</pub-id><pub-id pub-id-type="pmid">29203879</pub-id><pub-id pub-id-type="doi">10.1038/s41598-017-17204-5</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><article-title>STAR: Ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC3530905</pub-id><pub-id pub-id-type="pmid">23104886</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC4302049</pub-id><pub-id pub-id-type="pmid">25516281</pub-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberzon</surname><given-names>A</given-names></name><name><surname>Birger</surname><given-names>C</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Ghandi</surname><given-names>M</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name></person-group><article-title>The Molecular Signatures Database Hallmark Gene Set Collection</article-title><source>Cell Syst</source><year>2015</year><volume>1</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="pmcid">PMC4707969</pub-id><pub-id pub-id-type="pmid">26771021</pub-id><pub-id pub-id-type="doi">10.1016/j.cels.2015.12.004</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlén</surname><given-names>M</given-names></name><name><surname>Fagerberg</surname><given-names>L</given-names></name><name><surname>Hallström</surname><given-names>BM</given-names></name><name><surname>Lindskog</surname><given-names>C</given-names></name><name><surname>Oksvold</surname><given-names>P</given-names></name><name><surname>Mardinoglu</surname><given-names>A</given-names></name><name><surname>Sivertsson</surname><given-names>Å</given-names></name><name><surname>Kampf</surname><given-names>C</given-names></name><name><surname>Sjöstedt</surname><given-names>E</given-names></name><name><surname>Asplund</surname><given-names>A</given-names></name><etal/></person-group><article-title>Tissue-based map of the human proteome</article-title><source>Science (80-.)</source><year>2015</year><volume>347</volume><pub-id pub-id-type="pmid">25613900</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muraro</surname><given-names>MJ</given-names></name><name><surname>Dharmadhikari</surname><given-names>G</given-names></name><name><surname>Grün</surname><given-names>D</given-names></name><name><surname>Groen</surname><given-names>N</given-names></name><name><surname>Dielen</surname><given-names>T</given-names></name><name><surname>Jansen</surname><given-names>E</given-names></name><name><surname>van Gurp</surname><given-names>L</given-names></name><name><surname>Engelse</surname><given-names>MA</given-names></name><name><surname>Carlotti</surname><given-names>F</given-names></name><name><surname>de Koning</surname><given-names>EJP</given-names></name><etal/></person-group><article-title>A Single-Cell Transcriptome Atlas of the Human Pancreas</article-title><source>Cell Syst</source><year>2016</year><volume>3</volume><fpage>385</fpage><lpage>394</lpage><elocation-id>e3</elocation-id><pub-id pub-id-type="pmcid">PMC5092539</pub-id><pub-id pub-id-type="pmid">27693023</pub-id><pub-id pub-id-type="doi">10.1016/j.cels.2016.09.002</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><etal/></person-group><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><elocation-id>e29</elocation-id><pub-id pub-id-type="pmcid">PMC8238499</pub-id><pub-id pub-id-type="pmid">34062119</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>EY</given-names></name><name><surname>Tan</surname><given-names>CM</given-names></name><name><surname>Kou</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Meirelles</surname><given-names>GV</given-names></name><name><surname>Clark</surname><given-names>NR</given-names></name><name><surname>Ma’ayan</surname><given-names>A</given-names></name></person-group><article-title>Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool</article-title><source>BMC Bioinformatics</source><year>2013</year><volume>14</volume><elocation-id>128</elocation-id><pub-id pub-id-type="pmcid">PMC3637064</pub-id><pub-id pub-id-type="pmid">23586463</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-14-128</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Millard</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Slowikowski</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>Baglaenko</surname><given-names>Y</given-names></name><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Loh</surname><given-names>Pru</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name></person-group><article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title><source>Nat Methods</source><year>2019</year><volume>16</volume><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="pmcid">PMC6884693</pub-id><pub-id pub-id-type="pmid">31740819</pub-id><pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guinney</surname><given-names>J</given-names></name><name><surname>Dienstmann</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>de Reyniès</surname><given-names>A</given-names></name><name><surname>Schlicker</surname><given-names>A</given-names></name><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Marisa</surname><given-names>L</given-names></name><name><surname>Roepman</surname><given-names>P</given-names></name><name><surname>Nyamundanda</surname><given-names>G</given-names></name><name><surname>Angelino</surname><given-names>P</given-names></name><etal/></person-group><article-title>The consensus molecular subtypes of colorectal cancer</article-title><source>Nat Med</source><year>2015</year><volume>21</volume><fpage>1350</fpage><lpage>1356</lpage><pub-id pub-id-type="pmcid">PMC4636487</pub-id><pub-id pub-id-type="pmid">26457759</pub-id><pub-id pub-id-type="doi">10.1038/nm.3967</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>U</given-names></name><name><surname>Weigert</surname><given-names>M</given-names></name><name><surname>Broaddus</surname><given-names>C</given-names></name><name><surname>Myers</surname><given-names>G</given-names></name></person-group><source>Cell Detection with Star-Convex Polygons</source><person-group person-group-type="editor"><name><surname>Frangi</surname><given-names>AF</given-names></name><name><surname>Schnabel</surname><given-names>JA</given-names></name><name><surname>Davatzikos</surname><given-names>C</given-names></name><name><surname>Alberola-López</surname><given-names>C</given-names></name><name><surname>Fichtinger</surname><given-names>G</given-names></name></person-group><publisher-name>Springer International Publishing</publisher-name><year>2018</year><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-00934-2_30</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolhaqueiro</surname><given-names>ACF</given-names></name><name><surname>van Jaarsveld</surname><given-names>RH</given-names></name><name><surname>Ponsioen</surname><given-names>B</given-names></name><name><surname>Overmeer</surname><given-names>RM</given-names></name><name><surname>Snippert</surname><given-names>HJ</given-names></name><name><surname>Kops</surname><given-names>GJPL</given-names></name></person-group><article-title>Live imaging of cell division in 3D stem-cell organoid cultures</article-title><source>Methods Cell Biol</source><year>2018</year><volume>745</volume><fpage>91</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">29957217</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Roh</surname><given-names>SA</given-names></name><name><surname>Cho</surname><given-names>DH</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>JC</given-names></name></person-group><article-title>A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients</article-title><source>Mol Oncol</source><year>2014</year><volume>8</volume><fpage>1653</fpage><lpage>1666</lpage><pub-id pub-id-type="pmcid">PMC5528589</pub-id><pub-id pub-id-type="pmid">25049118</pub-id><pub-id pub-id-type="doi">10.1016/j.molonc.2014.06.016</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Patient-derived <italic>RNF43</italic>-mutant CRC organoids are growth factor self-sufficient.</title><p><bold>A.</bold> Heatmap of gene expression data for WNT markers or mucinous markers over a panel of CRC organoids (n = 8). Presence of <italic>RNF43</italic> or <italic>APC</italic> mutation is indicated on top. Unsupervised clustering into four groups shows that <italic>RNF43</italic>-mutant organoids cluster together in a low-WNT, high-mucinous group. Coloured bar represents row z-scores of normalised counts. <bold>B.</bold> Representative brightfield images showing healthy colon organoids and HUB040 CRC organoids cultured in CRC culture medium or complete colon organoid medium (including WNT, EGF and RSPO) for one passage and 14 days in total. Scale bar = 1000 μm. <bold>C.</bold> Line graphs showing normalized viability of HUB040 and P26T organoids treated with indicated concentration of PORCN inhibitor C59 for 7 days. Data were normalized to PBS-treated organoids. n = 2, mean + sd</p></caption><graphic xlink:href="EMS158981-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Repair of <italic>RNF43</italic> mutations in patient-derived organoids blocks metastasis and niche-independent outgrowth.</title><p><bold>A.</bold> Schematic of experimental setup of this study. <bold>B.</bold> Sanger sequencing traces of <italic>RNF43</italic>-corrected clones (RC1, RC2) and non-corrected control clone (NC1) compared to the locus of the HUB040 CRC organoid. <bold>C.</bold> Table showing tumour forming efficiency and tumour/metastatic load in caecum, liver and lung, 120 days after transplantation. Tumour and metastatic load were determined as human nucleoli area over total tissue area. <bold>D.</bold> Representative human nucleoli stainings of caecum, lung and liver of mice, 120 days after transplantation of indicated HUB040 clones. Scale bar = 200 μm <bold>E.</bold> Normalized viability of <italic>RNF43</italic> mutant and <italic>RNF43</italic>-corrected HUB040 clones treated as in <xref ref-type="supplementary-material" rid="SD3">Figure S2B</xref>. Results of six experiments are presented, including one to three replicates per condition per experiment (n =12 per condition in total). Data are normalised against mean value in complete medium per experiment. Kruskal-Wallis test is used to compare <italic>RNF43</italic> mutant and corrected within each condition.</p></caption><graphic xlink:href="EMS158981-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Mutant <italic>RNF43</italic> drives mucinous differentiation and niche factor production.</title><p><bold>A, B.</bold> Scatter plots showing log2 fold change of gene expression between <italic>RNF43-corrected</italic> clones, RC1 (Y-axis) and RC2 (X-axis), and HUB040 (<bold>A</bold>) or non-corrected clone 1 (NC1) (<bold>B</bold>). Genes with significant differential expression (FC &gt; 1.5 and p &lt; 0.05) in both comparisons are indicated as larger red dots. Downregulated genes of interest are annotated. Total number of genes that are up- or downregulated in both comparisons is plotted in the corners. <bold>C.</bold> GSEA plots showing enrichment of a colonic goblet cell signature<sup><xref ref-type="bibr" rid="R19">19</xref></sup> and REG4+ deep crypt secretory cell (DCS) signature<sup><xref ref-type="bibr" rid="R18">18</xref></sup> in HUB040 compared to RC1 or RC2. <bold>D.</bold> Representative confocal microscopy images of organoids stained for mucin2 (MUC2, in red), actin (phalloidin, green) and nuclei (dapi, blue). Scale bar = 10 μm. <bold>E.</bold> Representative IHC images for mucin2 (MUC2) on primary subcutaneous tumours. Scale bar = 250 μm. <bold>F.</bold> Box plots showing the percentage of MUC2+ tumour area in primary subcutaneous tumours. Significance was evaluated using a Krusak-Wallis test. <bold>G, H.</bold> Representative low-magnification brightfield images of HUB040 organoids treated with 100 nM PORCN inhibitor LGK-974 (<bold>G</bold>), 1 μM IR/IGFR inhibitor Linsitinib (<bold>H</bold>) or DMSO in CRC culture medium with or without WNT surrogate (<bold>G</bold>) or EGF (<bold>H</bold>) supplementation for 14 days, passaged after 7 days. Scale bar = 1000 μm. <bold>I.</bold> Representative 3D projected images of time-lapse series of hybrid HUB040-RC2 or pure RC2 organoids in CRC medium at the start and end of the time-lapse; nuclei are visualized by expression of H2B-mNeon or H2B-mCherry. Scale bar represent 20 μm. <bold>J.</bold> Result of analysis of RC2-cell fate over time in the two conditions. Cell death and mitotic events were counted for all RC2-H2B-mNeon cells in 13-14 movies per condition. The ratio of number of cell death over mitotic events is shown.</p></caption><graphic xlink:href="EMS158981-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Mutant <italic>RNF43</italic> promotes tumour-intrinsic niche cell formation.</title><p><bold>A.</bold> Reduced dimensionality (UMAP) visualisation of single cell RNA sequencing data of HUB040 organoids cultured in CRC medium. Results of unsupervised clustering are colour-coded per cluster. <bold>B, c.</bold> Violin plots showing scaled single cell expression levels of proliferation marker MKI67 (<bold>B</bold>) and cancer stem-cell marker ASCL2 (<bold>C</bold>) grouped by cluster. <bold>D, E.</bold> Violin plots showing single cell module scores for expression of genes from a colonic goblet cell signature<sup><xref ref-type="bibr" rid="R19">19</xref></sup> (<bold>D</bold>) and REG4+ deep crypt secretory cell (DCS) signature<sup><xref ref-type="bibr" rid="R18">18</xref></sup> (<bold>E</bold>) grouped by cluster. <bold>F.</bold> Plot showing the fraction of cells that were scored as TINC in the analysis of single cell RNA sequencing data of the four indicated organoid lines. <bold>G.</bold> Dot-plot showing the average expression and fraction of cells expressing indicated TINC marker genes. <bold>H.</bold> Schematic of the endogenous TINC reporter construct. <bold>I.</bold> Representative confocal microscopy pictures of TINC reporter-positive cells (mNeon) in HUB040 organoids, combined with KI67 immunostaining. Scale bar = 10 μm. <bold>J.</bold> FACS plot of HUB040 TINC reporter organoids gated for low, medium or high mNeon signal showing the result of EdU labelling after 16h incubation with EdU. <bold>K.</bold> Histograms showing distribution of mNeon fluorescence by FACS of TINC reporter organoids that were sorted according to <xref ref-type="supplementary-material" rid="SD3">Figure S5A</xref> into mNeon-high, -medium and -low cells and allowed to reconstitute into heterogeneous organoids for 12 days. <bold>L.</bold> GSEA plots showing enrichment of the TINC signature that was derived from single cell RNAseq and the ‘RNF43-mutation dependent secretory gene signature’ as defined in <xref ref-type="supplementary-material" rid="SD3">Figure S2E</xref> for TINC reporter high versus low cells. <bold>M.</bold> Heatmap showing Z-scores for the expression of selected genes (TINC markers, growth factors, WNT target genes and regenerative genes) in the TINC reporter low, medium and high cells.</p></caption><graphic xlink:href="EMS158981-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>TINCs are enriched in <italic>RNF43</italic> mutant CRC patients and metastatic lesions.</title><p><bold>A, B.</bold> Box plots showing log2 Z-scores for the TINC signature (top 25 differentially expressed marker genes of HUB040 cluster 1 as determined in single cell RNAseq analysis) over the colon adenocarcinoma TCGA bulk RNA sequencing dataset grouped by <italic>RNF43</italic>-mutation status (n = 46 mut, 337 wt) (<bold>A</bold>) or pathology classification as mucinous (n = 37) or non-mucinous (n = 346) (<bold>b</bold>). <bold>C.</bold> Box plots showing expression of TINC signature (RMA normalization data) in microarray data of 186 primary tumours, 48 liver metastases and 20 lung metastases.<sup><xref ref-type="bibr" rid="R51">51</xref></sup> <bold>D.</bold> Violin plot showing single cell module scores for expression of genes from the TINC signature of single cells from 39 patients of Joanito et al<sup><xref ref-type="bibr" rid="R6">6</xref></sup> (iCMS2, 25 patients; iCMS3_RNF43wt, 10 patients; iCMS3_RNF43mut, 4 patients). Percentage of cells scoring above threshold of 0.55 is indicated. <bold>E.</bold> Reduced dimensionality (UMAP) visualisation of supervised clustering using 154 TINC signature genes of 18.320 single cells from 28 patients by Joanito et al<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. <bold>F.</bold> Box plots showing the fraction of cells in cluster 3 or 5, divided by <italic>RNF43</italic> mutation status per patient. The red dot marks a patient that has a <italic>RNF43</italic> and <italic>APC</italic> mutation. <bold>G.</bold> Violin plot showing single cell module scores for expression of genes from the TINC signature grouped by cluster.</p></caption><graphic xlink:href="EMS158981-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>A tight window of WNT signalling balances tumour niche cells and stem cells.</title><p><bold>A.</bold> Representative confocal microscopy pictures of organoids with IF labelling for β-catenin. Scale bar = 20 μm. <bold>B.</bold> Violin plot showing quantification of nuclear β-catenin signal for 205-231 cells per organoid line. <bold>C, d.</bold> Results of GSEA analysis comparing HUB040<sup><italic>APC-/-</italic></sup> with HUB040 (WNT activation, blue) and HUB040 treated with 100 nM LGK-974 for 24 or 48 hours with DMSO treatment (WNT inhibition, orange and green) by gene signatures of colon-specific cell types<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup> (<bold>C</bold>) or HUB040-specific clusters as determined in <xref ref-type="fig" rid="F3">Figure 3a</xref> (<bold>D</bold>). x-axis shows the normalized enrichment score (NES) and size of the dots shows the false discovery rate (FDR). <bold>E.</bold> Violin plots showing single cell module scores for expression of genes from the HUB040 TINC signature grouped by organoid line of origin. <bold>F.</bold> Scatter plot showing inverse relation between single cell module scores for expression of genes from the HUB040 TINC signature and the Van der Flier WNT signature<sup><xref ref-type="bibr" rid="R52">52</xref></sup>. Colour of dots indicates line of origin. <bold>G.</bold> Line graph showing fraction of <italic>APC</italic> mutant DNA after each passage in the competition assay of indicated lines. n = 3. <bold>H.</bold> Box plots showing the relative viability of HUB040 organoids after 14 days treatment with 5 μM CHIR99021 or DMSO control. n = 3 per condition. <bold>I.</bold> Representative confocal microscopy images of HUB040 NDRG1-IRES-mNeon (TINC reporter) organoids after three days treatment with LGK-974 or DMSO control. Scale bar = 50 μm. <bold>J.</bold> Schematic representation of the optimal window of WNT-signalling for fitness of colorectal mucinous adenocarcinomas. <bold>K.</bold> Diagram of the biological model presented in the discussion comparing two routes towards of niche-independency in cancer.</p></caption><graphic xlink:href="EMS158981-f006"/></fig></floats-group></article>